Craig Mayer, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID

Study Counts

Type Study_count
Total_Studies 1725
interventional 869
Observational 727
Registry 129

Studies over Time

Total studies by type over time

Total studies by type over time

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 248
Drug|placebo 159
Biological 81
Other 76
Device 45
Behavioral 43
Drug|Other 38
Diagnostic Test 32
Biological|placebo 26
Procedure 20
Biological|Drug 13
Biological|Other 10
Dietary Supplement 9
Dietary Supplement|Drug 7
Radiation 7
Device|Other 5
Dietary Supplement|placebo 4
Biological|Drug|placebo 3
Combination Product 3
Combination Product|Drug 3
Device|Drug|Procedure 3
Dietary Supplement|Other 3
Behavioral|Other 2
Biological|Other|placebo 2
Device|Drug 2
Device|Drug|Radiation 2
Device|placebo 2
Device|Procedure 2
Dietary Supplement|Drug|placebo 2
Drug|Other|placebo 2
Behavioral|Biological 1
Behavioral|Diagnostic Test 1
Biological|Device|Other 1
Biological|Genetic|Other 1
Combination Product|placebo 1
Diagnostic Test|Dietary Supplement 1
Diagnostic Test|Drug|Other|placebo 1
Diagnostic Test|Other 1
Dietary Supplement|Drug|Other 1
Drug|placebo|Procedure 1
Drug|placebo|Radiation 1
Drug|Procedure 1
Other|placebo 1
Other|Procedure 1
Other|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country Study_Count
United States 269
France 74
China 60
Spain 45
Italy 29
United Kingdom 27
Canada 25
Brazil 24
Mexico 22
Iran, Islamic Republic of 17
Belgium 16
Egypt 16
Russian Federation 15
Turkey 15
Germany 14
Pakistan 14
Denmark 11
India 10
Argentina 9
Greece 9
Sweden 9
Netherlands 8
Saudi Arabia 7
Switzerland 7
Australia 6
Israel 6
Hong Kong 5
Poland 5
Bangladesh 4
Singapore 4
Austria 3
Chile 3
Korea, Republic of 3
Norway 3
Qatar 3
Hungary 2
Indonesia 2
Iraq 2
South Africa 2
United States|Canada 2
United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 2
Argentina|Brazil|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain 1
Austria|Belgium|France|Luxembourg 1
Austria|Denmark|Germany 1
Austria|Germany 1
Bahrain 1
Belarus 1
Belgium|Brazil|France|Germany|Italy|Spain 1
Belgium|France|Monaco 1
Belgium|Germany 1
Bosnia and Herzegovina 1
Brazil|Italy 1
Bulgaria|Germany 1
Canada|Mongolia 1
Canada|United States 1
China|Indonesia 1
China|Italy 1
Czechia 1
Denmark|Germany|Hungary|Netherlands 1
Dominican Republic 1
Ecuador 1
France|Monaco 1
French Guiana 1
Germany|Sweden 1
Gibraltar 1
Guinea-Bissau 1
Honduras 1
Iceland 1
India|United Kingdom 1
Japan 1
Jordan 1
Kazakhstan 1
Kuwait 1
Malaysia 1
North Macedonia 1
Puerto Rico 1
Romania 1
Rwanda 1
Slovenia 1
Taiwan 1
Thailand 1
Thailand|United Kingdom 1
Tunisia 1
Ukraine 1
United Arab Emirates 1
United States|Argentina|Brazil|Germany|Italy|Japan|Mexico|Russian Federation|Spain|United Kingdom 1
United States|Austria|France|Israel|Spain|United Kingdom 1
United States|Brazil|Canada|Mexico 1
United States|Brazil|Russian Federation 1
United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Canada|Germany|Italy|Russian Federation|Spain|United Kingdom 1
United States|Canada|Spain 1
United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|Denmark|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom 1
United States|France|Germany|Italy|Russian Federation|Spain|United Kingdom 1
United States|France|Netherlands|Spain|United Kingdom 1
United States|France|Spain|United Kingdom 1
United States|Israel 1
United States|Kenya|Mexico|Peru|South Africa 1
United States|Puerto Rico 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 551
2 83
3 36
4 36
5 18
6 19
7 16
8 12
9 13
10 7
11 10
12 7
13 3
14 8
15 4
16 2
17 1
18 1
20 2
21 1
22 3
24 4
25 1
26 1
27 2
28 1
29 1
30 1
31 3
33 1
34 1
37 2
39 1
40 2
47 3
53 1
59 1
60 1
62 1
65 1
67 1
68 2
69 1
71 1
183 1
184 1

Phase

Phase Study_Count
N/A 284
Phase 2 239
Phase 3 134
Phase 2/Phase 3 59
Phase 1/Phase 2 54
Phase 4 47
Phase 1 39
Early Phase 1 13

Number of Arms

Number_of_Arms Count_of_Studies
1 162
2 537
3 82
4 50
5 9
6 8
7 2
8 4
9 2
11 1
12 1
13 1
15 1
17 1
22 1
30 1
NA 6

Number of Updates

Count of Versions Count of Studies
1 236
2 233
3 177
4 101
5 46
6 18
7 20
8 6
9 8
10 9
11 4
12 4
13 1
14 1
18 2
19 2
44 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 1690 633 2.669826
Contacts/Locations 998 500 1.996000
None (earliest Version on record) 869 869 1.000000
Recruitment Status 515 453 1.136865
Outcome Measures 359 270 1.329630
Eligibility 329 222 1.481982
Oversight 291 271 1.073801
Study Description 275 208 1.322115
Study Identification 256 203 1.261084
Study Design 231 178 1.297753
Arms 225 179 1.256983
Interventions 225 179 1.256983
Sponsor/Collaborators 105 88 1.193182
Conditions 86 72 1.194444
IPDSharing 34 32 1.062500
References 28 27 1.037037
Documents 11 10 1.100000
Results Submission Events 2 2 1.000000

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9.00000 4.000 5.00000 5.0000 5.0000 12.0000 1.0000 10.0000
1st Qu. 10.00000 48.750 28.50000 27.0000 50.0000 110.0000 222.5000 70.0000
Median 50.00000 100.000 40.00000 47.5000 106.0000 300.0000 450.0000 170.0000
Mean 57.61538 5473.049 66.53846 816.5185 230.9372 925.0508 927.2537 458.0426
3rd Qu. 100.00000 318.250 100.00000 187.5000 210.0000 512.0000 1032.5000 601.0000
Max. 150.00000 506517.000 300.00000 32000.0000 10000.0000 15000.0000 10078.0000 3400.0000

Trial Group Type

group_type Group_Count
Experimental 1073
Active Comparator 317
Placebo Comparator 267
No Intervention 192
Other 100
Sham Comparator 10
NA 6

Intervention Model

intervention_model Study_Count
Parallel Assignment 628
Single Group Assignment 183
Sequential Assignment 32
Crossover Assignment 13
Factorial Assignment 13

Primary Purpose

primary_purpose Study_Count
Treatment 607
Prevention 109
Diagnostic 45
Supportive Care 39
Other 37
Health Services Research 17
Basic Science 8
Screening 5
Device Feasibility 2

Vaccines

nct_id brief_title link
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04357028 Measles Vaccine in HCW https://ClinicalTrials.gov/show/NCT04357028
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04368728
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04400838 Investigating a Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04400838
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04405908 SCB-2019 as COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04405908
NCT04453852 Monovalent Recombinant COVID19 Vaccine https://ClinicalTrials.gov/show/NCT04453852
NCT04444674 COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection https://ClinicalTrials.gov/show/NCT04444674
NCT04445194 Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04445194
NCT04449276 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults https://ClinicalTrials.gov/show/NCT04449276
NCT04450004 Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. https://ClinicalTrials.gov/show/NCT04450004
NCT04445389 Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04445389
NCT04445428 OPV as Potential Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04445428
NCT04470609 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years https://ClinicalTrials.gov/show/NCT04470609
NCT04475302 BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots https://ClinicalTrials.gov/show/NCT04475302

Phase

phase Study_Count
Phase 1 10
Phase 1/Phase 2 10
Phase 2 2
Phase 2/Phase 3 1
Phase 3 2
Phase 4 1

Country

country Study_Count
Australia 3
Belgium 1
Canada 2
China 8
Egypt 1
Germany 2
Guinea-Bissau 1
India 1
Korea, Republic of 1
Mongolia 1
South Africa 1
United Kingdom 2
United States 4

Site Count

Site_count Study_Count
1 14
2 3
3 4
4 1
6 2
10 1
20 1

Arms

number_of_arms Study_Count
1 3
2 5
3 5
4 3
5 1
6 1
8 2
9 1
12 1
13 1
15 1
22 1
30 1

Enrollment

Measure Vaccine
Min 20.000
1st Qu 120.000
Median 195.000
Mean 2156.423
3rd Qu 892.500
Max 32000.000

Model

intervention_model Study_Count
Crossover Assignment 1
Parallel Assignment 11
Sequential Assignment 10
Single Group Assignment 4

Group Types

group_type Group_Count
Experimental 110
Active Comparator 37
Placebo Comparator 19
No Intervention 1
Other 1

Update Count

Count of Versions Count of Studies
1 4
2 6
3 8
4 2
5 3
7 1
9 1
11 1

Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 64 22 2.909091
Contacts/Locations 35 20 1.750000
None (earliest Version on record) 26 26 1.000000
Recruitment Status 21 16 1.312500
Study Design 16 7 2.285714
Study Identification 16 11 1.454546
Arms 15 9 1.666667
Interventions 15 9 1.666667
Eligibility 12 6 2.000000
Study Description 12 7 1.714286
Outcome Measures 9 7 1.285714
Oversight 9 9 1.000000
Conditions 5 2 2.500000
Sponsor/Collaborators 4 4 1.000000
IPDSharing 2 2 1.000000
References 1 1 1.000000

Observational Studies

Studies by Country

Country Study_Count
France 177
United States 101
Italy 54
Egypt 44
United Kingdom 38
Turkey 37
China 34
Spain 32
Germany 21
Switzerland 16
Canada 12
Denmark 12
Belgium 11
India 10
Austria 8
Norway 8
Brazil 7
Hong Kong 7
Sweden 7
Argentina 5
Israel 5
Mexico 5
Russian Federation 5
Greece 4
Hungary 4
Malaysia 3
Monaco 3
Portugal 3
Qatar 3
Saudi Arabia 3
Singapore 3
Australia 2
Czechia 2
France|French Guiana 2
Luxembourg 2
Netherlands 2
Poland 2
Algeria 1
Argentina|Bosnia and Herzegovina|Ghana|India|Iran, Islamic Republic of|Sudan 1
Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland 1
Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|Italy|United Kingdom 1
Brazil|Chile|Uruguay 1
Burkina Faso 1
Chile 1
Colombia 1
Denmark|France|Germany|Norway 1
Ecuador 1
Finland|France|Germany|Italy|Sweden|United Kingdom 1
France|Germany|Spain 1
France|Guadeloupe|Martinique 1
France|Martinique 1
Germany|Romania 1
Iran, Islamic Republic of 1
Italy|Romania|United Kingdom 1
Italy|San Marino 1
Japan 1
Jordan 1
Korea, Republic of 1
Pakistan 1
Slovenia 1
Spain|United States|Denmark|France|Germany|Italy|United Kingdom 1
United Arab Emirates 1
United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan 1
United States|Argentina|Armenia|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela 1
United States|Argentina|Botswana|Brazil|Kenya|Malawi|Mexico|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe 1
United States|Egypt|Germany|Peru|Singapore 1
United States|Egypt|Iran, Islamic Republic of 1
United States|Malawi|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 593
2 42
3 25
4 7
5 11
6 8
7 6
8 3
9 4
11 2
12 2
13 1
14 3
16 1
17 3
19 1
20 2
21 1
22 1
23 1
34 1
41 1
42 1
58 1
60 1
69 1
81 1
97 1
128 1
637 1

Number of Updates

Count of Versions Count of Studies
1 308
2 252
3 93
4 37
5 12
6 4
7 5
8 2
10 1
11 2
12 1
13 1
24 1
25 1
30 1
34 1
37 1
39 1
47 1
59 1
65 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 1064 419 2.539379
None (earliest Version on record) 727 727 1.000000
Contacts/Locations 355 243 1.460905
Recruitment Status 227 200 1.135000
Study Description 164 139 1.179856
Outcome Measures 151 135 1.118518
Study Identification 142 127 1.118110
Study Design 108 97 1.113402
Eligibility 97 86 1.127907
Oversight 84 80 1.050000
Groups 54 47 1.148936
Interventions 54 47 1.148936
Sponsor/Collaborators 54 50 1.080000
Conditions 40 38 1.052632
References 19 19 1.000000
IPDSharing 6 6 1.000000
Documents 5 4 1.250000

Enrollment Metrics

Measure Observational
Min 5.00
1st Qu 100.00
Median 300.00
Mean 39527.96
3rd Qu 1000.00
Max 10000000.00

Observation Model

observational_model Study_Count
Cohort 450
Case-Only 95
Other 77
Case-Control 63
Ecologic or Community 28
Case-Crossover 8
Family-Based 5
NA 1

Time Perspective

time_perspective Study_Count
Prospective 426
Retrospective 161
Cross-Sectional 91
Other 48
NA 1

Registries

Studies by Country

Country Study_Count
France 22
United States 18
Spain 13
Italy 10
Turkey 7
Germany 6
Belgium 5
Sweden 5
China 3
Denmark 3
Switzerland 3
United Kingdom 3
Austria 2
Bangladesh 2
Egypt 2
Mexico 2
Norway 2
Poland 2
Russian Federation 2
Argentina 1
Australia 1
Belgium|France 1
Brazil 1
Canada 1
China|Hong Kong|Spain 1
France|Martinique 1
Hungary 1
India 1
Netherlands 1
Qatar 1
Singapore 1
Tunisia 1
Ukraine 1
United States|Brazil|Colombia|France|Spain 1
United States|Canada|Israel|Japan|Serbia|Spain|United Kingdom 1
United States|Poland 1

Sites per Study

Site_count Study_Count
1 99
2 9
3 1
4 2
6 1
7 2
9 1
10 1
11 2
15 1
17 2
18 1
27 1
31 1
38 1
41 1
47 1
75 1
76 1

Number of Updates

Count of Versions Count of Studies
1 53
2 45
3 20
4 6
6 3
7 1
12 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 134 76 1.763158
None (earliest Version on record) 129 129 1.000000
Contacts/Locations 70 42 1.666667
Recruitment Status 37 36 1.027778
Study Description 25 22 1.136364
Study Design 24 22 1.090909
Outcome Measures 23 20 1.150000
Study Identification 23 21 1.095238
Eligibility 13 13 1.000000
Oversight 13 13 1.000000
Groups 9 9 1.000000
Interventions 9 9 1.000000
Sponsor/Collaborators 7 7 1.000000
Conditions 6 6 1.000000
References 5 5 1.000000
Documents 4 2 2.000000
More Information 3 1 3.000000
IPDSharing 2 2 1.000000
Results 1 1 1.000000
Results Submission Events 1 1 1.000000

Enrollment Metrics

Measure Registries
Min 1.00
1st Qu 100.00
Median 300.00
Mean 27885.41
3rd Qu 1231.00
Max 3000000.00

Registry Model

observational_model Study_Count
Cohort 94
Case-Control 15
Case-Only 11
Other 8
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 97
Other 22
Cross-Sectional 10

Follow-up

target_duration Study_Count
1 Year 19
6 Months 15
1 Month 14
12 Months 14
3 Months 10
1 Day 6
2 Months 6
2 Years 5
30 Days 4
4 Weeks 4
20 Years 3
14 Days 2
2 Weeks 2
28 Days 2
3 Weeks 2
3 Years 2
5 Years 2
1 Week 1
10 Days 1
14 Weeks 1
18 Months 1
20 Days 1
20 Months 1
21 Days 1
24 Months 1
5 Days 1
5 Months 1
6 Weeks 1
60 Days 1
7 Days 1
7 Months 1
8 Weeks 1
9 Months 1
9 Weeks 1

Overview of trials

Interventional Trials

nct_id brief_title link
NCT04244591 Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04244591
NCT04252118 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04252118
NCT04251871 Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04251871
NCT04252274 Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04252274
NCT04252885 The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04252885
NCT04263402 The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia https://ClinicalTrials.gov/show/NCT04263402
NCT04255017 A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04255017
NCT04254874 A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04254874
NCT04264533 Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia https://ClinicalTrials.gov/show/NCT04264533
NCT04261270 A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04261270
NCT04331613 Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS https://ClinicalTrials.gov/show/NCT04331613
NCT04275245 Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04275245
NCT04261517 Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04261517
NCT04269525 Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia https://ClinicalTrials.gov/show/NCT04269525
NCT04282902 A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04282902
NCT04276688 Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment https://ClinicalTrials.gov/show/NCT04276688
NCT04280224 NK Cells Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04280224
NCT04304313 A Pilot Study of Sildenafil in COVID-19 https://ClinicalTrials.gov/show/NCT04304313
NCT04275414 Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04275414
NCT04273763 Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04273763
NCT04279197 Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu https://ClinicalTrials.gov/show/NCT04279197
NCT04273321 Efficacy and Safety of Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04273321
NCT04276896 Immunity and Safety of Covid-19 Synthetic Minigene Vaccine https://ClinicalTrials.gov/show/NCT04276896
NCT04343794 Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 https://ClinicalTrials.gov/show/NCT04343794
NCT04280588 Fingolimod in COVID-19 https://ClinicalTrials.gov/show/NCT04280588
NCT04280705 Adaptive COVID-19 Treatment Trial (ACTT) https://ClinicalTrials.gov/show/NCT04280705
NCT04283461 Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04283461
NCT04288102 Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04288102
NCT04291729 Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04291729
NCT04292899 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04292899
NCT04292730 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment https://ClinicalTrials.gov/show/NCT04292730
NCT04308317 Tetrandrine Tablets Used in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04308317
NCT04299724 Safety and Immunity of Covid-19 aAPC Vaccine https://ClinicalTrials.gov/show/NCT04299724
NCT04304053 Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention https://ClinicalTrials.gov/show/NCT04304053
NCT04303507 Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting https://ClinicalTrials.gov/show/NCT04303507
NCT04306055 Blood Donor Recruitment During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04306055
NCT04310228 Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04310228
NCT04305106 Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT https://ClinicalTrials.gov/show/NCT04305106
NCT04304690 COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04304690
NCT04305457 Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04305457
NCT04306393 Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 https://ClinicalTrials.gov/show/NCT04306393
NCT04308668 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04308668
NCT04316377 Norwegian Coronavirus Disease 2019 Study https://ClinicalTrials.gov/show/NCT04316377
NCT04311177 Losartan for Patients With COVID-19 Not Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04311177
NCT04312009 Losartan for Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04312009
NCT04315948 Trial of Treatments for COVID-19 in Hospitalized Adults https://ClinicalTrials.gov/show/NCT04315948
NCT04315480 Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis https://ClinicalTrials.gov/show/NCT04315480
NCT04311697 Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure https://ClinicalTrials.gov/show/NCT04311697
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04315298
NCT04313322 Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04313322
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults https://ClinicalTrials.gov/show/NCT04313127
NCT04312243 NO Prevention of COVID-19 for Healthcare Providers https://ClinicalTrials.gov/show/NCT04312243
NCT04313023 The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04313023
NCT04312997 The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04312997
NCT04323514 Use of Ascorbic Acid in Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04323514
NCT04321174 COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir https://ClinicalTrials.gov/show/NCT04321174
NCT04315896 Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) https://ClinicalTrials.gov/show/NCT04315896
NCT04320056 Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04320056
NCT04318015 Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) https://ClinicalTrials.gov/show/NCT04318015
NCT04317040 CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04317040
NCT04323527 Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 https://ClinicalTrials.gov/show/NCT04323527
NCT04317092 Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) https://ClinicalTrials.gov/show/NCT04317092
NCT04321928 Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary https://ClinicalTrials.gov/show/NCT04321928
NCT04319900 Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04319900
NCT04319445 Mindfulness During COVID-19 https://ClinicalTrials.gov/show/NCT04319445
NCT04318444 Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04318444
NCT04324606 A Study of a Candidate COVID-19 Vaccine (COV001) https://ClinicalTrials.gov/show/NCT04324606
NCT04318431 Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children https://ClinicalTrials.gov/show/NCT04318431
NCT04325867 Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04325867
NCT04320953 Non-contact Endoscopy at Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04320953
NCT04320238 Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff https://ClinicalTrials.gov/show/NCT04320238
NCT04319731 A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04319731
NCT04328961 Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) https://ClinicalTrials.gov/show/NCT04328961
NCT04328129 Household Transmission Investigation Study for COVID-19 in French Guiana https://ClinicalTrials.gov/show/NCT04328129
NCT04323345 Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus https://ClinicalTrials.gov/show/NCT04323345
NCT04322682 Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) https://ClinicalTrials.gov/show/NCT04322682
NCT04322396 Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04322396
NCT04322344 Escin in Patients With Covid-19 Infection https://ClinicalTrials.gov/show/NCT04322344
NCT04321616 The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients https://ClinicalTrials.gov/show/NCT04321616
NCT04321421 Hyperimmune Plasma for Critical Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04321421
NCT04321096 The Impact of Camostat Mesilate on COVID-19 Infection https://ClinicalTrials.gov/show/NCT04321096
NCT04320615 A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04320615
NCT04321278 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) https://ClinicalTrials.gov/show/NCT04321278
NCT04330690 Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial https://ClinicalTrials.gov/show/NCT04330690
NCT04327349 Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial https://ClinicalTrials.gov/show/NCT04327349
NCT04326920 Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) https://ClinicalTrials.gov/show/NCT04326920
NCT04322773 Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure https://ClinicalTrials.gov/show/NCT04322773
NCT04322123 Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04322123
NCT04321993 Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04321993
NCT04322565 Colchicine Counteracting Inflammation in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04322565
NCT04323800 Convalescent Plasma to Stem Coronavirus (CSSC-001) https://ClinicalTrials.gov/show/NCT04323800
NCT04371601 Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04371601
NCT04353271 Trial of Hydroxychloroquine In Covid-19 Kinetics https://ClinicalTrials.gov/show/NCT04353271
NCT04336462 Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04336462
NCT04328285 Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers https://ClinicalTrials.gov/show/NCT04328285
NCT04327505 Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04327505
NCT04326452 Treating COVID-19 With a Bidirectional Oxygenation Valve https://ClinicalTrials.gov/show/NCT04326452
NCT04325893 Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease https://ClinicalTrials.gov/show/NCT04325893
NCT04325061 Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04325061
NCT04324996 A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 https://ClinicalTrials.gov/show/NCT04324996
NCT04324528 Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation https://ClinicalTrials.gov/show/NCT04324528
NCT04324489 DAS181 for Severe COVID-19: Compassionate Use https://ClinicalTrials.gov/show/NCT04324489
NCT04324073 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI https://ClinicalTrials.gov/show/NCT04324073
NCT04324021 Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04324021
NCT04324463 Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial https://ClinicalTrials.gov/show/NCT04324463
NCT04327206 BCG Vaccination to Protect Healthcare Workers Against COVID-19 https://ClinicalTrials.gov/show/NCT04327206
NCT04355962 Sevoflurane in COVID-19 ARDS (SevCov) https://ClinicalTrials.gov/show/NCT04355962
NCT04329533 Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04329533
NCT04326790 The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention https://ClinicalTrials.gov/show/NCT04326790
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326426
NCT04326036 Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection https://ClinicalTrials.gov/show/NCT04326036
NCT04325906 Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS https://ClinicalTrials.gov/show/NCT04325906
NCT04324190 DIgital Online SuPport for COVID-19 StrEss https://ClinicalTrials.gov/show/NCT04324190
NCT04327401 COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III https://ClinicalTrials.gov/show/NCT04327401
NCT04327388 Sarilumab COVID-19 https://ClinicalTrials.gov/show/NCT04327388
NCT04331899 Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04331899
NCT04328493 The Vietnam Chloroquine Treatment on COVID-19 https://ClinicalTrials.gov/show/NCT04328493
NCT04328467 Pre-exposure Prophylaxis for SARS-Coronavirus-2 https://ClinicalTrials.gov/show/NCT04328467
NCT04328441 Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine https://ClinicalTrials.gov/show/NCT04328441
NCT04328012 COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04328012
NCT04336254 Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04336254
NCT04329195 ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic https://ClinicalTrials.gov/show/NCT04329195
NCT04333368 Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS https://ClinicalTrials.gov/show/NCT04333368
NCT04331054 Protective Role of Inhaled Steroids for Covid-19 Infection https://ClinicalTrials.gov/show/NCT04331054
NCT04348370 BCG Vaccine for Health Care Workers as Defense Against COVID 19 https://ClinicalTrials.gov/show/NCT04348370
NCT04331600 Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 https://ClinicalTrials.gov/show/NCT04331600
NCT04331470 Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04331470
NCT04329923 The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) https://ClinicalTrials.gov/show/NCT04329923
NCT04329832 Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04329832
NCT04328480 The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04328480
NCT04332107 Azithromycin for COVID-19 Treatment in Outpatients Nationwide https://ClinicalTrials.gov/show/NCT04332107
NCT04376515 Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) https://ClinicalTrials.gov/show/NCT04376515
NCT04352348 Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being https://ClinicalTrials.gov/show/NCT04352348
NCT04347174 A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04347174
NCT04343651 Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04343651
NCT04342182 Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) https://ClinicalTrials.gov/show/NCT04342182
NCT04336332 Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04336332
NCT04335305 Checkpoint Blockade in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04335305
NCT04335123 Study of Open Label Losartan in COVID-19 https://ClinicalTrials.gov/show/NCT04335123
NCT04333355 Safety in Convalescent Plasma Transfusion to COVID-19 https://ClinicalTrials.gov/show/NCT04333355
NCT04332991 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease https://ClinicalTrials.gov/show/NCT04332991
NCT04332094 Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04332094
NCT04331808 CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) https://ClinicalTrials.gov/show/NCT04331808
NCT04331366 Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04331366
NCT04329650 Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04329650
NCT04330638 Treatment of COVID-19 Patients With Anti-interleukin Drugs https://ClinicalTrials.gov/show/NCT04330638
NCT04339712 Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction https://ClinicalTrials.gov/show/NCT04339712
NCT04338009 Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04338009
NCT04335097 Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04335097
NCT04334265 Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04334265
NCT04334044 Treatment of SARS Caused by COVID-19 With Ruxolitinib https://ClinicalTrials.gov/show/NCT04334044
NCT04333589 Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive https://ClinicalTrials.gov/show/NCT04333589
NCT04333550 Application of Desferal to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04333550
NCT04333420 Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04333420
NCT04333407 Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. https://ClinicalTrials.gov/show/NCT04333407
NCT04333225 Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers https://ClinicalTrials.gov/show/NCT04333225
NCT04331795 Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04331795
NCT04335279 Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program https://ClinicalTrials.gov/show/NCT04335279
NCT04335136 Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04335136
NCT04347226 Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347226
NCT04345523 Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345523
NCT04340349 Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals https://ClinicalTrials.gov/show/NCT04340349
NCT04339660 Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04339660
NCT04337541 Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System https://ClinicalTrials.gov/show/NCT04337541
NCT04335851 Video-Based Exercises and Well-Being During Social Isolation https://ClinicalTrials.gov/show/NCT04335851
NCT04335786 Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease https://ClinicalTrials.gov/show/NCT04335786
NCT04335071 Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04335071
NCT04334928 Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel https://ClinicalTrials.gov/show/NCT04334928
NCT04334850 Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04334850
NCT04334629 LIBERATE Trial in COVID-19 https://ClinicalTrials.gov/show/NCT04334629
NCT04334382 Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 https://ClinicalTrials.gov/show/NCT04334382
NCT04335084 A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04335084
NCT04334512 A Study of Quintuple Therapy to Treat COVID-19 Infection https://ClinicalTrials.gov/show/NCT04334512
NCT04334460 Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects https://ClinicalTrials.gov/show/NCT04334460
NCT04348409 Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04348409
NCT04343053 Pro-thrombotic Status in Patients With SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04343053
NCT04340544 Hydroxychloroquine for the Treatment of Mild COVID-19 Disease https://ClinicalTrials.gov/show/NCT04340544
NCT04337008 Renin Angiotensin System - CoronaVirus https://ClinicalTrials.gov/show/NCT04337008
NCT04336904 Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 https://ClinicalTrials.gov/show/NCT04336904
NCT04336774 CAPTION AI to Minimize Risk of COVID Exposure https://ClinicalTrials.gov/show/NCT04336774
NCT04335552 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04335552
NCT04336410 Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04336410
NCT04338568 Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study https://ClinicalTrials.gov/show/NCT04338568
NCT04342650 Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04342650
NCT04341116 Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04341116
NCT04338698 Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT https://ClinicalTrials.gov/show/NCT04338698
NCT04343092 Efficacy of Ivermectin as Add on Therapy in COVID19 Patients https://ClinicalTrials.gov/show/NCT04343092
NCT04341675 Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04341675
NCT04338841 HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04338841
NCT04338828 Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED https://ClinicalTrials.gov/show/NCT04338828
NCT04346797 CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04346797
NCT04344951 Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04344951
NCT04340557 Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04340557
NCT04339816 Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial https://ClinicalTrials.gov/show/NCT04339816
NCT04338074 TXA and Corona Virus 2019 (COVID19) in Outpatients https://ClinicalTrials.gov/show/NCT04338074
NCT04337918 Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection https://ClinicalTrials.gov/show/NCT04337918
NCT04349631 A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04349631
NCT04384380 Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384380
NCT04353674 Modulation of Hyperinflammation in COVID-19 https://ClinicalTrials.gov/show/NCT04353674
NCT04352933 PROLIFIC ChemoprophylaxisTrial (COVID-19) https://ClinicalTrials.gov/show/NCT04352933
NCT04347031 A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 https://ClinicalTrials.gov/show/NCT04347031
NCT04346147 Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04346147
NCT04345848 Preventing COVID-19 Complications With Low- and High-dose Anticoagulation https://ClinicalTrials.gov/show/NCT04345848
NCT04344210 Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04344210
NCT04342169 University of Utah COVID-19 Hydrochloroquine Trial https://ClinicalTrials.gov/show/NCT04342169
NCT04341493 Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04341493
NCT04341441 Will Hydroxychloroquine Impede or Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04341441
NCT04341415 Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome https://ClinicalTrials.gov/show/NCT04341415
NCT04341389 A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) https://ClinicalTrials.gov/show/NCT04341389
NCT04341038 Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury https://ClinicalTrials.gov/show/NCT04341038
NCT04340050 COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04340050
NCT04339426 Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection https://ClinicalTrials.gov/show/NCT04339426
NCT04338958 Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation https://ClinicalTrials.gov/show/NCT04338958
NCT04341922 A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04341922
NCT04364893 Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 https://ClinicalTrials.gov/show/NCT04364893
NCT04358081 Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04358081
NCT04350580 Polyvalent Immunoglobulin in COVID-19 Related ARds https://ClinicalTrials.gov/show/NCT04350580
NCT04348383 Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. https://ClinicalTrials.gov/show/NCT04348383
NCT04347681 Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 https://ClinicalTrials.gov/show/NCT04347681
NCT04346693 An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 https://ClinicalTrials.gov/show/NCT04346693
NCT04346420 Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 https://ClinicalTrials.gov/show/NCT04346420
NCT04345653 Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers https://ClinicalTrials.gov/show/NCT04345653
NCT04344236 Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344236
NCT04344106 Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study https://ClinicalTrials.gov/show/NCT04344106
NCT04343768 An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04343768
NCT04343261 Convalescent Plasma in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343261
NCT04343248 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) https://ClinicalTrials.gov/show/NCT04343248
NCT04342728 Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation https://ClinicalTrials.gov/show/NCT04342728
NCT04342689 The Role of Resistant Starch in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342689
NCT04342663 A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04342663
NCT04341207 Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients https://ClinicalTrials.gov/show/NCT04341207
NCT04344457 Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04344457
NCT04342221 Hydroxychloroquine for COVID-19 https://ClinicalTrials.gov/show/NCT04342221
NCT04344587 Awake Prone Position for Early Hypoxemia in COVID-19 https://ClinicalTrials.gov/show/NCT04344587
NCT04341142 Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER https://ClinicalTrials.gov/show/NCT04341142
NCT04343755 Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343755
NCT04353037 PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04353037
NCT04351906 Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04351906
NCT04348513 Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04348513
NCT04347980 Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 https://ClinicalTrials.gov/show/NCT04347980
NCT04346589 Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04346589
NCT04345692 A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04345692
NCT04344015 COVID-19 Plasma Collection https://ClinicalTrials.gov/show/NCT04344015
NCT04344730 Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04344730
NCT04344431 Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04344431
NCT04344080 Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04344080
NCT04344041 COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) https://ClinicalTrials.gov/show/NCT04344041
NCT04343989 A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04343989
NCT04343976 Pegylated Interferon Lambda Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04343976
NCT04346615 Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen https://ClinicalTrials.gov/show/NCT04346615
NCT04343729 Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 https://ClinicalTrials.gov/show/NCT04343729
NCT04343963 Pyridostigmine in Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04343963
NCT04390178 Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04390178
NCT04351724 Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) https://ClinicalTrials.gov/show/NCT04351724
NCT04348929 Birth Experience During COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04348929
NCT04345991 Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort https://ClinicalTrials.gov/show/NCT04345991
NCT04345549 Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04345549
NCT04345289 Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04345289
NCT04345276 Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04345276
NCT04344600 Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04344600
NCT04344561 Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation https://ClinicalTrials.gov/show/NCT04344561
NCT04344535 Convalescent Plasma vs. Standard Plasma for COVID-19 https://ClinicalTrials.gov/show/NCT04344535
NCT04344444 Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease https://ClinicalTrials.gov/show/NCT04344444
NCT04344288 Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04344288
NCT04342897 A Study of LY3127804 in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04342897
NCT04348305 Hydrocortisone for COVID-19 and Severe Hypoxia https://ClinicalTrials.gov/show/NCT04348305
NCT04347538 Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04347538
NCT04347382 Honey & Nigella Sativa Trial Against COVID-19 https://ClinicalTrials.gov/show/NCT04347382
NCT04345419 A Real-life Experience on Treatment of Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04345419
NCT04356495 Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04356495
NCT04349410 The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol https://ClinicalTrials.gov/show/NCT04349410
NCT04349371 Saved From COVID-19 https://ClinicalTrials.gov/show/NCT04349371
NCT04463433 Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China https://ClinicalTrials.gov/show/NCT04463433
NCT04360824 Covid-19 Associated Coagulopathy https://ClinicalTrials.gov/show/NCT04360824
NCT04359251 Different PEEP Settings of COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04359251
NCT04357340 The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04357340
NCT04355728 Use of UC-MSCs for COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355728
NCT04349241 Efficacy and Safety of Favipiravir in Management of COVID-19 https://ClinicalTrials.gov/show/NCT04349241
NCT04348864 COVID-19 Antibody Self-testing Using Virtual Point-of-care https://ClinicalTrials.gov/show/NCT04348864
NCT04348695 Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. https://ClinicalTrials.gov/show/NCT04348695
NCT04348656 CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) https://ClinicalTrials.gov/show/NCT04348656
NCT04348500 Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease https://ClinicalTrials.gov/show/NCT04348500
NCT04347954 PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) https://ClinicalTrials.gov/show/NCT04347954
NCT04347239 Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04347239
NCT04346667 Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04346667
NCT04346017 Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome https://ClinicalTrials.gov/show/NCT04346017
NCT04350281 Double Therapy With IFN-beta 1b and Hydroxychloroquine https://ClinicalTrials.gov/show/NCT04350281
NCT04382391 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04382391
NCT04361916 Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) https://ClinicalTrials.gov/show/NCT04361916
NCT04357808 Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) https://ClinicalTrials.gov/show/NCT04357808
NCT04357106 COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma https://ClinicalTrials.gov/show/NCT04357106
NCT04355143 Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) https://ClinicalTrials.gov/show/NCT04355143
NCT04354831 A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354831
NCT04354610 Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04354610
NCT04353596 Stopping ACE-inhibitors in COVID-19 https://ClinicalTrials.gov/show/NCT04353596
NCT04352608 Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04352608
NCT04351542 Ayurveda for Flu Like Illness During Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04351542
NCT04351763 Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms https://ClinicalTrials.gov/show/NCT04351763
NCT04351620 High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 https://ClinicalTrials.gov/show/NCT04351620
NCT04351581 Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04351581
NCT04351191 PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds https://ClinicalTrials.gov/show/NCT04351191
NCT04350736 First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04350736
NCT04350684 Umifenovir in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350684
NCT04350671 Interferon Beta 1a in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04350671
NCT04350593 Dapagliflozin in Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350593
NCT04350320 Trial to Study the Benefit of Colchicine in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04350320
NCT04349228 Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals https://ClinicalTrials.gov/show/NCT04349228
NCT04349098 Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04349098
NCT04346446 Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients https://ClinicalTrials.gov/show/NCT04346446
NCT04347915 The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04347915
NCT04348435 A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04348435
NCT04357327 Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04357327
NCT04356534 Convalescent Plasma Trial in COVID -19 Patients https://ClinicalTrials.gov/show/NCT04356534
NCT04355897 CoVID-19 Plasma in Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355897
NCT04355637 Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04355637
NCT04355364 Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE) https://ClinicalTrials.gov/show/NCT04355364
NCT04355026 Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04355026
NCT04351516 Test and Treat COVID 65plus+ https://ClinicalTrials.gov/show/NCT04351516
NCT04351347 The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04351347
NCT04351152 Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04351152
NCT04353336 Efficacay of Chloroquine in COVID-19 Treatment https://ClinicalTrials.gov/show/NCT04353336
NCT04359290 Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS https://ClinicalTrials.gov/show/NCT04359290
NCT04351243 A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) https://ClinicalTrials.gov/show/NCT04351243
NCT04352959 COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses https://ClinicalTrials.gov/show/NCT04352959
NCT04367662 Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 https://ClinicalTrials.gov/show/NCT04367662
NCT04361838 The COVID-19 ICU PRAYER Study https://ClinicalTrials.gov/show/NCT04361838
NCT04361344 Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361344
NCT04358939 Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) https://ClinicalTrials.gov/show/NCT04358939
NCT04354870 COVID-19 PrEP HCW HCQ Study https://ClinicalTrials.gov/show/NCT04354870
NCT04354428 Treatment for COVID-19 in High-Risk Adult Outpatients https://ClinicalTrials.gov/show/NCT04354428
NCT04354259 Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 https://ClinicalTrials.gov/show/NCT04354259
NCT04353128 Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. https://ClinicalTrials.gov/show/NCT04353128
NCT04352751 Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 https://ClinicalTrials.gov/show/NCT04352751
NCT04358549 Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04358549
NCT04359264 Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04359264
NCT04353284 Camostat Mesylate in COVID-19 Outpatients https://ClinicalTrials.gov/show/NCT04353284
NCT04353206 Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure https://ClinicalTrials.gov/show/NCT04353206
NCT04373044 Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 https://ClinicalTrials.gov/show/NCT04373044
NCT04364009 Anakinra for COVID-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04364009
NCT04363853 Tocilizumab Treatment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04363853
NCT04361942 Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) https://ClinicalTrials.gov/show/NCT04361942
NCT04357782 Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation https://ClinicalTrials.gov/show/NCT04357782
NCT04356690 Etoposide in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356690
NCT04356482 CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 https://ClinicalTrials.gov/show/NCT04356482
NCT04355351 Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) https://ClinicalTrials.gov/show/NCT04355351
NCT04355247 Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm https://ClinicalTrials.gov/show/NCT04355247
NCT04355936 Telmisartan for Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04355936
NCT04377308 Fluoxetine to Reduce Intubation and Death After COVID19 Infection https://ClinicalTrials.gov/show/NCT04377308
NCT04357730 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04357730
NCT04376034 Convalescent Plasma Collection and Treatment in Pediatrics and Adults https://ClinicalTrials.gov/show/NCT04376034
NCT04358614 Baricitinib Therapy in COVID-19 https://ClinicalTrials.gov/show/NCT04358614
NCT04363814 Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363814
NCT04356937 Efficacy of Tocilizumab on Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04356937
NCT04357028 Measles Vaccine in HCW https://ClinicalTrials.gov/show/NCT04357028
NCT04374084 Moxibustion Plus Cupping in Convalescent Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374084
NCT04368845 Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study https://ClinicalTrials.gov/show/NCT04368845
NCT04368156 Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04368156
NCT04366063 Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04366063
NCT04362085 Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care https://ClinicalTrials.gov/show/NCT04362085
NCT04359680 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04359680
NCT04359537 Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 https://ClinicalTrials.gov/show/NCT04359537
NCT04359277 A Randomized Trial of Anticoagulation Strategies in COVID-19 https://ClinicalTrials.gov/show/NCT04359277
NCT04358003 Plasma Adsorption in Patients With Confirmed COVID-19 https://ClinicalTrials.gov/show/NCT04358003
NCT04357990 Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19 https://ClinicalTrials.gov/show/NCT04357990
NCT04357366 suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) https://ClinicalTrials.gov/show/NCT04357366
NCT04358068 Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04358068
NCT04359797 COVID-19 Patient Positioning Pragmatic Trial https://ClinicalTrials.gov/show/NCT04359797
NCT04364763 A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) https://ClinicalTrials.gov/show/NCT04364763
NCT04359901 Sarilumab for Patients With Moderate COVID-19 Disease https://ClinicalTrials.gov/show/NCT04359901
NCT04413864 Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 https://ClinicalTrials.gov/show/NCT04413864
NCT04363385 Collection of Biological Samples With Clinical Characterization of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04363385
NCT04362176 Passive Immunity Trial of Nashville II for COVID-19 https://ClinicalTrials.gov/show/NCT04362176
NCT04361526 Pilot Study on Cytokine Filtration in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04361526
NCT04359862 Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection https://ClinicalTrials.gov/show/NCT04359862
NCT04359810 Plasma Therapy of COVID-19 in Critically Ill Patients https://ClinicalTrials.gov/show/NCT04359810
NCT04359329 Estrogen Patch for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04359329
NCT04358926 Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) https://ClinicalTrials.gov/show/NCT04358926
NCT04358783 Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia https://ClinicalTrials.gov/show/NCT04358783
NCT04363736 A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04363736
NCT04362189 Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04362189
NCT04373200 Human Ab Response & immunoMONItoring of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04373200
NCT04366882 Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366882
NCT04366323 Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 https://ClinicalTrials.gov/show/NCT04366323
NCT04366245 Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04366245
NCT04366089 Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora https://ClinicalTrials.gov/show/NCT04366089
NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) https://ClinicalTrials.gov/show/NCT04365101
NCT04364737 Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04364737
NCT04364594 COVID-19 Search in Conjunctival Cells https://ClinicalTrials.gov/show/NCT04364594
NCT04361474 Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity https://ClinicalTrials.gov/show/NCT04361474
NCT04361214 Leflunomide in Mild COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361214
NCT04360980 The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection https://ClinicalTrials.gov/show/NCT04360980
NCT04360837 PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04360837
NCT04360811 Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360811
NCT04361396 Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361396
NCT04362137 Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) https://ClinicalTrials.gov/show/NCT04362137
NCT04377750 The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation https://ClinicalTrials.gov/show/NCT04377750
NCT04368377 Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04368377
NCT04366947 Intravascular Access in Suspected/Confirmed COVID-19 Patient https://ClinicalTrials.gov/show/NCT04366947
NCT04366297 Intravascular Access of COVID-19 Patient Under Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04366297
NCT04366271 Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04366271
NCT04365582 OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome https://ClinicalTrials.gov/show/NCT04365582
NCT04364022 Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland https://ClinicalTrials.gov/show/NCT04364022
NCT04363502 Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection https://ClinicalTrials.gov/show/NCT04363502
NCT04363450 Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) https://ClinicalTrials.gov/show/NCT04363450
NCT04363437 COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04363437
NCT04363346 Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia https://ClinicalTrials.gov/show/NCT04363346
NCT04361253 Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy https://ClinicalTrials.gov/show/NCT04361253
NCT04393961 At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study https://ClinicalTrials.gov/show/NCT04393961
NCT04385095 Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04385095
NCT04372589 Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) https://ClinicalTrials.gov/show/NCT04372589
NCT04368988 Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant https://ClinicalTrials.gov/show/NCT04368988
NCT04368923 Management of Covid-19 Patients During Home Isolation https://ClinicalTrials.gov/show/NCT04368923
NCT04368260 Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04368260
NCT04368000 Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04368000
NCT04367168 Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease https://ClinicalTrials.gov/show/NCT04367168
NCT04366960 Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04366960
NCT04366791 Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04366791
NCT04365972 Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04365972
NCT04365608 Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04365608
NCT04365309 Protective Effect of Aspirin on COVID-19 Patients https://ClinicalTrials.gov/show/NCT04365309
NCT04365257 Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) https://ClinicalTrials.gov/show/NCT04365257
NCT04365127 Progesterone for the Treatment of COVID-19 in Hospitalized Men https://ClinicalTrials.gov/show/NCT04365127
NCT04363827 Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04363827
NCT04363606 Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability https://ClinicalTrials.gov/show/NCT04363606
NCT04363593 Serology COVID-19 From the Cornwall Hospital Union https://ClinicalTrials.gov/show/NCT04363593
NCT04362813 Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia https://ClinicalTrials.gov/show/NCT04362813
NCT04363372 A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04363372
NCT04365153 Canakinumab in Covid-19 Cardiac Injury (The Three C Study) https://ClinicalTrials.gov/show/NCT04365153
NCT04366050 Ramipril for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04366050
NCT04392778 Clinical Use of Stem Cells for the Treatment of Covid-19 https://ClinicalTrials.gov/show/NCT04392778
NCT04372017 Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection https://ClinicalTrials.gov/show/NCT04372017
NCT04365699 Cardiovascular Effects of COVID-19 https://ClinicalTrials.gov/show/NCT04365699
NCT04364802 COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients https://ClinicalTrials.gov/show/NCT04364802
NCT04368299 Telemedicine for Follow-up of Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04368299
NCT04428268 Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04428268
NCT04373824 Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study https://ClinicalTrials.gov/show/NCT04373824
NCT04370782 Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting https://ClinicalTrials.gov/show/NCT04370782
NCT04365738 Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04365738
NCT04365985 Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 https://ClinicalTrials.gov/show/NCT04365985
NCT04389710 Convalescent Plasma for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389710
NCT04379453 Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses https://ClinicalTrials.gov/show/NCT04379453
NCT04374565 Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia https://ClinicalTrials.gov/show/NCT04374565
NCT04372693 Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement https://ClinicalTrials.gov/show/NCT04372693
NCT04370262 Multi-site Adaptive Trials for COVID-19 https://ClinicalTrials.gov/show/NCT04370262
NCT04369456 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients https://ClinicalTrials.gov/show/NCT04369456
NCT04369365 A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04369365
NCT04369066 COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie https://ClinicalTrials.gov/show/NCT04369066
NCT04367831 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04367831
NCT04367545 Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367545
NCT04367077 MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) https://ClinicalTrials.gov/show/NCT04367077
NCT04366180 Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers https://ClinicalTrials.gov/show/NCT04366180
NCT04368728 Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults https://ClinicalTrials.gov/show/NCT04368728
NCT04410354 Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 https://ClinicalTrials.gov/show/NCT04410354
NCT04406181 Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04406181
NCT04376476 Host-pathogen Interactions During SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04376476
NCT04371640 Sirolimus in COVID-19 Phase 1 https://ClinicalTrials.gov/show/NCT04371640
NCT04371510 Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients https://ClinicalTrials.gov/show/NCT04371510
NCT04371419 COVID-19 Health Messaging to Underserved Communities https://ClinicalTrials.gov/show/NCT04371419
NCT04371393 MSCs in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04371393
NCT04371029 Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS https://ClinicalTrials.gov/show/NCT04371029
NCT04370886 Recruit Blood Donors Via SMS During Epidemic of COVID-19 https://ClinicalTrials.gov/show/NCT04370886
NCT04369469 Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia https://ClinicalTrials.gov/show/NCT04369469
NCT04379154 Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04379154
NCT04385810 Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 https://ClinicalTrials.gov/show/NCT04385810
NCT04384588 COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) https://ClinicalTrials.gov/show/NCT04384588
NCT04380532 Tableted COVID-19 Therapeutic Vaccine https://ClinicalTrials.gov/show/NCT04380532
NCT04378712 Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04378712
NCT04375202 Colchicine in COVID-19: a Pilot Study https://ClinicalTrials.gov/show/NCT04375202
NCT04372186 A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04372186
NCT04370938 Provider Burnout During COVID-19 https://ClinicalTrials.gov/show/NCT04370938
NCT04371367 Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) https://ClinicalTrials.gov/show/NCT04371367
NCT04370288 Clinical Application of Methylene Blue for Treatment of Covid-19 Patients https://ClinicalTrials.gov/show/NCT04370288
NCT04369820 C5a Receptor Expression - COVID-19 (C5-COV) https://ClinicalTrials.gov/show/NCT04369820
NCT04408066 COVID-19: A POC Test Under Research & Evaluation https://ClinicalTrials.gov/show/NCT04408066
NCT04379531 LDCT in COVID-19 Pneumonia: a Prospective Moscow Study https://ClinicalTrials.gov/show/NCT04379531
NCT04374942 Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? https://ClinicalTrials.gov/show/NCT04374942
NCT04374032 Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374032
NCT04373161 Home Pulse Oximeter Use in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04373161
NCT04373135 Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 https://ClinicalTrials.gov/show/NCT04373135
NCT04372680 WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound https://ClinicalTrials.gov/show/NCT04372680
NCT04370834 Tocilizumab for Patients With Cancer and COVID-19 Disease https://ClinicalTrials.gov/show/NCT04370834
NCT04373460 Convalescent Plasma to Limit SARS-CoV-2 Associated Complications https://ClinicalTrials.gov/show/NCT04373460
NCT04372628 Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 https://ClinicalTrials.gov/show/NCT04372628
NCT04378738 Social Media and Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04378738
NCT04377789 Effect of Quercetin on Prophylaxis and Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04377789
NCT04375124 Treatment of Angiotensin Peptide (1-7) for COVID-19 https://ClinicalTrials.gov/show/NCT04375124
NCT04374786 Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374786
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707
NCT04379271 A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) https://ClinicalTrials.gov/show/NCT04379271
NCT04374461 A Study of N-acetylcysteine in Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04374461
NCT04373733 Early Intervention in COVID-19: Favipiravir Verses Standard Care https://ClinicalTrials.gov/show/NCT04373733
NCT04376788 Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04376788
NCT04374019 Novel Agents for Treatment of High-risk COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04374019
NCT04374591 Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series https://ClinicalTrials.gov/show/NCT04374591
NCT04374526 Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. https://ClinicalTrials.gov/show/NCT04374526
NCT04374539 Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04374539
NCT04392531 Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 https://ClinicalTrials.gov/show/NCT04392531
NCT04376814 Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 https://ClinicalTrials.gov/show/NCT04376814
NCT04375098 Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04375098
NCT04394455 Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms https://ClinicalTrials.gov/show/NCT04394455
NCT04376593 PET/CT Imaging in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04376593
NCT04391712 Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease https://ClinicalTrials.gov/show/NCT04391712
NCT04388527 COVID-19 Convalescent Plasma for Mechanically Ventilated Population https://ClinicalTrials.gov/show/NCT04388527
NCT04385043 Hyperimmune Plasma in Patients With COVID-19 Severe Infection https://ClinicalTrials.gov/show/NCT04385043
NCT04380818 Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 https://ClinicalTrials.gov/show/NCT04380818
NCT04379336 BCG Vaccination for Healthcare Workers in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04379336
NCT04378803 Mindfulness Training for Seniors https://ClinicalTrials.gov/show/NCT04378803
NCT04377672 Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04377672
NCT04377659 Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04377659
NCT04377620 Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) https://ClinicalTrials.gov/show/NCT04377620
NCT04377477 COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) https://ClinicalTrials.gov/show/NCT04377477
NCT04375397 Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury https://ClinicalTrials.gov/show/NCT04375397
NCT04376684 Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease https://ClinicalTrials.gov/show/NCT04376684
NCT04392713 Efficacy of Ivermectin in COVID-19 https://ClinicalTrials.gov/show/NCT04392713
NCT04389372 Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse https://ClinicalTrials.gov/show/NCT04389372
NCT04383613 Prone Positioning for Patients on General Medical Wards With COVID19 https://ClinicalTrials.gov/show/NCT04383613
NCT04379661 SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 https://ClinicalTrials.gov/show/NCT04379661
NCT04379492 A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 https://ClinicalTrials.gov/show/NCT04379492
NCT04379076 InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort https://ClinicalTrials.gov/show/NCT04379076
NCT04378920 A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715) https://ClinicalTrials.gov/show/NCT04378920
NCT04377711 A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04377711
NCT04379037 Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients https://ClinicalTrials.gov/show/NCT04379037
NCT04381884 Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04381884
NCT04377100 Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses https://ClinicalTrials.gov/show/NCT04377100
NCT04433910 A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04433910
NCT04385901 Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth https://ClinicalTrials.gov/show/NCT04385901
NCT04383535 Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia https://ClinicalTrials.gov/show/NCT04383535
NCT04382768 Inhaled Ibuprofen to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04382768
NCT04382092 Co-infection Management in COVID-19 Critically Ill https://ClinicalTrials.gov/show/NCT04382092
NCT04381858 Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04381858
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701
NCT04380519 Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04380519
NCT04380376 Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia https://ClinicalTrials.gov/show/NCT04380376
NCT04390477 Study to Evaluate the Effect of a Probiotic in COVID-19 https://ClinicalTrials.gov/show/NCT04390477
NCT04390022 Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial https://ClinicalTrials.gov/show/NCT04390022
NCT04390139 Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 https://ClinicalTrials.gov/show/NCT04390139
NCT04384497 Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study https://ClinicalTrials.gov/show/NCT04384497
NCT04382040 A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04382040
NCT04381962 A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) https://ClinicalTrials.gov/show/NCT04381962
NCT04381377 Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 https://ClinicalTrials.gov/show/NCT04381377
NCT04380961 A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 https://ClinicalTrials.gov/show/NCT04380961
NCT04380909 ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation https://ClinicalTrials.gov/show/NCT04380909
NCT04382586 Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants https://ClinicalTrials.gov/show/NCT04382586
NCT04381000 Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04381000
NCT04382066 Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382066
NCT04381936 Randomised Evaluation of COVID-19 Therapy https://ClinicalTrials.gov/show/NCT04381936
NCT04380688 Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. https://ClinicalTrials.gov/show/NCT04380688
NCT04382755 Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure https://ClinicalTrials.gov/show/NCT04382755
NCT04405986 Exploring Brain Damages After COVID-19 Infection https://ClinicalTrials.gov/show/NCT04405986
NCT04394416 Trial of Imatinib for Hospitalized Adults With COVID-19 https://ClinicalTrials.gov/show/NCT04394416
NCT04390464 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) https://ClinicalTrials.gov/show/NCT04390464
NCT04389294 HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists https://ClinicalTrials.gov/show/NCT04389294
NCT04386694 Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04386694
NCT04384965 Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04384965
NCT04382729 Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia https://ClinicalTrials.gov/show/NCT04382729
NCT04382547 Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04382547
NCT04381988 A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy https://ClinicalTrials.gov/show/NCT04381988
NCT04394377 Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial https://ClinicalTrials.gov/show/NCT04394377
NCT04400929 Using GM-CSF as a Host Directed Therapeutic Against COVID-19 https://ClinicalTrials.gov/show/NCT04400929
NCT04382651 Study of Efficacy and Safety of MAS825 in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04382651
NCT04382053 Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04382053
NCT04389333 Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389333
NCT04385199 Convalescent Plasma for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385199
NCT04392973 FAvipiravir and HydroxyChloroquine Combination Therapy https://ClinicalTrials.gov/show/NCT04392973
NCT04391140 Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS https://ClinicalTrials.gov/show/NCT04391140
NCT04385017 Role of Inflammasomes in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04385017
NCT04385836 Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) https://ClinicalTrials.gov/show/NCT04385836
NCT04446104 A Preventive Treatment for Migrant Workers at High-risk of Covid-19 https://ClinicalTrials.gov/show/NCT04446104
NCT04442191 Convalescent Plasma as a Possible Treatment for COVID-19 https://ClinicalTrials.gov/show/NCT04442191
NCT04393636 Digital Cardiac Counseling Trial: DCC Trial https://ClinicalTrials.gov/show/NCT04393636
NCT04388514 Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure https://ClinicalTrials.gov/show/NCT04388514
NCT04387409 Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04387409
NCT04386850 Oral 25-hydroxyvitamin D3 and COVID-19 https://ClinicalTrials.gov/show/NCT04386850
NCT04384900 Accelerated Prone Position Ventilation of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04384900
NCT04386291 Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 https://ClinicalTrials.gov/show/NCT04386291
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04386616
NCT04412330 Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 https://ClinicalTrials.gov/show/NCT04412330
NCT04387253 Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID https://ClinicalTrials.gov/show/NCT04387253
NCT04391127 Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04391127
NCT04390191 Early CPAP in COVID-19 Confirmed or Suspected Patients https://ClinicalTrials.gov/show/NCT04390191
NCT04389944 Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 https://ClinicalTrials.gov/show/NCT04389944
NCT04389385 COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) https://ClinicalTrials.gov/show/NCT04389385
NCT04387292 Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic https://ClinicalTrials.gov/show/NCT04387292
NCT04400838 Investigating a Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04400838
NCT04386668 Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04386668
NCT04392414 Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease https://ClinicalTrials.gov/show/NCT04392414
NCT04388826 COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 https://ClinicalTrials.gov/show/NCT04388826
NCT04388683 Inhaled Nitric Oxide for Preventing Progression in COVID-19 https://ClinicalTrials.gov/show/NCT04388683
NCT04416919 Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment https://ClinicalTrials.gov/show/NCT04416919
NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older https://ClinicalTrials.gov/show/NCT04405076
NCT04394169 Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04394169
NCT04390412 Low Dose Radiotherapy in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04390412
NCT04389840 Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure https://ClinicalTrials.gov/show/NCT04389840
NCT04420390 Low Dose Radiotherapy for COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04420390
NCT04390516 Respiratory Decompensation and Model for the Triage of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04390516
NCT04390503 Convalescent Plasma for COVID-19 Close Contacts https://ClinicalTrials.gov/show/NCT04390503
NCT04389450 Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04389450
NCT04397718 Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization https://ClinicalTrials.gov/show/NCT04397718
NCT04395144 COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss https://ClinicalTrials.gov/show/NCT04395144
NCT04394182 Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 https://ClinicalTrials.gov/show/NCT04394182
NCT04393948 Lung Irradiation for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04393948
NCT04392323 Incidence of COVID-19 Test Conversion in Post-surgical Patients https://ClinicalTrials.gov/show/NCT04392323
NCT04392232 A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection https://ClinicalTrials.gov/show/NCT04392232
NCT04392141 Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 https://ClinicalTrials.gov/show/NCT04392141
NCT04391179 Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 https://ClinicalTrials.gov/show/NCT04391179
NCT04400799 Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04400799
NCT04393727 Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393727
NCT04407208 Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407208
NCT04393246 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms https://ClinicalTrials.gov/show/NCT04393246
NCT04396106 Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04396106
NCT04395105 Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT04395105
NCT04407130 Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. https://ClinicalTrials.gov/show/NCT04407130
NCT04398004 Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early https://ClinicalTrials.gov/show/NCT04398004
NCT04394793 Low Dose Radiation Therapy for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04394793
NCT04394442 Hydroxychloroquine in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04394442
NCT04405999 Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease https://ClinicalTrials.gov/show/NCT04405999
NCT04403269 NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE https://ClinicalTrials.gov/show/NCT04403269
NCT04402918 Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy https://ClinicalTrials.gov/show/NCT04402918
NCT04399317 Flow Controlled Ventilation in ARDS Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04399317
NCT04395807 Helmet CPAP Versus HFNC in COVID-19 https://ClinicalTrials.gov/show/NCT04395807
NCT04393792 SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 https://ClinicalTrials.gov/show/NCT04393792
NCT04393038 ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04393038
NCT04394117 Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease https://ClinicalTrials.gov/show/NCT04394117
NCT04416360 Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04416360
NCT04407286 Vitamin D Testing and Treatment for COVID 19 https://ClinicalTrials.gov/show/NCT04407286
NCT04402203 Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh https://ClinicalTrials.gov/show/NCT04402203
NCT04399746 Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 https://ClinicalTrials.gov/show/NCT04399746
NCT04399005 The Efficacy Comparing Daily and After-each-case Room Disinfection. https://ClinicalTrials.gov/show/NCT04399005
NCT04397562 A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04397562
NCT04397510 Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04397510
NCT04399252 Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 https://ClinicalTrials.gov/show/NCT04399252
NCT04399967 COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 https://ClinicalTrials.gov/show/NCT04399967
NCT04397692 Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) https://ClinicalTrials.gov/show/NCT04397692
NCT04397757 COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. https://ClinicalTrials.gov/show/NCT04397757
NCT04441684 Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) https://ClinicalTrials.gov/show/NCT04441684
NCT04403477 Convalescent Plasma Therapy in Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04403477
NCT04402970 Dornase Alfa for ARDS in Patients With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04402970
NCT04401293 Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients https://ClinicalTrials.gov/show/NCT04401293
NCT04398277 A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04398277
NCT04397666 RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04397666
NCT04397523 Efficacy and Safety of COVID-19 Convalescent Plasma https://ClinicalTrials.gov/show/NCT04397523
NCT04413006 Self-compassion for Chronic Pain Virtual Group Treatment Program https://ClinicalTrials.gov/show/NCT04413006
NCT04412538 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 https://ClinicalTrials.gov/show/NCT04412538
NCT04401202 Nigella Sativa in COVID-19 https://ClinicalTrials.gov/show/NCT04401202
NCT04400305 “Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” https://ClinicalTrials.gov/show/NCT04400305
NCT04399889 hCT-MSCs for COVID19 ARDS https://ClinicalTrials.gov/show/NCT04399889
NCT04399681 The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 https://ClinicalTrials.gov/show/NCT04399681
NCT04399109 Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) https://ClinicalTrials.gov/show/NCT04399109
NCT04399980 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04399980
NCT04410549 Pulmonary Optical Coherence Tomography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410549
NCT04400058 Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression https://ClinicalTrials.gov/show/NCT04400058
NCT04411602 Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD https://ClinicalTrials.gov/show/NCT04411602
NCT04410016 Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study https://ClinicalTrials.gov/show/NCT04410016
NCT04408183 GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel https://ClinicalTrials.gov/show/NCT04408183
NCT04407390 Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly https://ClinicalTrials.gov/show/NCT04407390
NCT04402983 The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients https://ClinicalTrials.gov/show/NCT04402983
NCT04402866 TD-0903 for ALI Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04402866
NCT04402840 Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) https://ClinicalTrials.gov/show/NCT04402840
NCT04402060 A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 https://ClinicalTrials.gov/show/NCT04402060
NCT04404361 PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer https://ClinicalTrials.gov/show/NCT04404361
NCT04402879 CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals https://ClinicalTrials.gov/show/NCT04402879
NCT04401579 Adaptive COVID-19 Treatment Trial 2 (ACTT-2) https://ClinicalTrials.gov/show/NCT04401579
NCT04411433 Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04411433
NCT04406493 Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique https://ClinicalTrials.gov/show/NCT04406493
NCT04403100 Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” https://ClinicalTrials.gov/show/NCT04403100
NCT04429711 Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04429711
NCT04412356 Timing of Tracheotomy in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04412356
NCT04408456 Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04408456
NCT04406246 Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide https://ClinicalTrials.gov/show/NCT04406246
NCT04403685 Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers https://ClinicalTrials.gov/show/NCT04403685
NCT04417335 Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination https://ClinicalTrials.gov/show/NCT04417335
NCT04408209 Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection https://ClinicalTrials.gov/show/NCT04408209
NCT04405908 SCB-2019 as COVID-19 Vaccine https://ClinicalTrials.gov/show/NCT04405908
NCT04407182 Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 https://ClinicalTrials.gov/show/NCT04407182
NCT04430608 Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients https://ClinicalTrials.gov/show/NCT04430608
NCT04410562 Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy https://ClinicalTrials.gov/show/NCT04410562
NCT04409496 Chat-based Support for Preveting Smoking Relapse https://ClinicalTrials.gov/show/NCT04409496
NCT04405570 A Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19 https://ClinicalTrials.gov/show/NCT04405570
NCT04405544 Determination of Acute Encephalopathy Predictors in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04405544
NCT04405310 Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial https://ClinicalTrials.gov/show/NCT04405310
NCT04405739 The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2 (The END-COVID Study) https://ClinicalTrials.gov/show/NCT04405739
NCT04414618 A Study of Opaganib in Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04414618
NCT04410692 Can the Prediction Market Improve Predictions of COVID-19? https://ClinicalTrials.gov/show/NCT04410692
NCT04410159 Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410159
NCT04407689 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort https://ClinicalTrials.gov/show/NCT04407689
NCT04444271 Mesenchymal Stem Cell Infusion for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04444271
NCT04457609 Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04457609
NCT04416308 COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) https://ClinicalTrials.gov/show/NCT04416308
NCT04409743 Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04409743
NCT04409522 Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04409522
NCT04409327 Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes https://ClinicalTrials.gov/show/NCT04409327
NCT04408131 Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study https://ClinicalTrials.gov/show/NCT04408131
NCT04412486 COVID-19 Convalescent Plasma (CCP) Transfusion https://ClinicalTrials.gov/show/NCT04412486
NCT04409509 Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID‑19) https://ClinicalTrials.gov/show/NCT04409509
NCT04433546 PB1046, a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). https://ClinicalTrials.gov/show/NCT04433546
NCT04417257 Study of LAU-7b for the Treatment of COVID-19 Disease in Adults https://ClinicalTrials.gov/show/NCT04417257
NCT04409262 A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04409262
NCT04427098 Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients https://ClinicalTrials.gov/show/NCT04427098
NCT04424901 Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04424901
NCT04415073 A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19 https://ClinicalTrials.gov/show/NCT04415073
NCT04412343 The Seniors COvid-19 Pandemic and Exercise Study https://ClinicalTrials.gov/show/NCT04412343
NCT04412057 Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury https://ClinicalTrials.gov/show/NCT04412057
NCT04412018 An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04412018
NCT04411667 Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04411667
NCT04410458 Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial) https://ClinicalTrials.gov/show/NCT04410458
NCT04411628 A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 https://ClinicalTrials.gov/show/NCT04411628
NCT04416139 Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 https://ClinicalTrials.gov/show/NCT04416139
NCT04412239 To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04412239
NCT04414371 Tools for Wellbeing COVID-19 National Study of Undergraduate Students https://ClinicalTrials.gov/show/NCT04414371
NCT04415086 Treatment of Patients With COVID-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04415086
NCT04414124 A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 https://ClinicalTrials.gov/show/NCT04414124
NCT04412772 A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS https://ClinicalTrials.gov/show/NCT04412772
NCT04412668 Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 https://ClinicalTrials.gov/show/NCT04412668
NCT04412291 A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study https://ClinicalTrials.gov/show/NCT04412291
NCT04412785 Cyclosporine in Patients With Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04412785
NCT04417270 Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge https://ClinicalTrials.gov/show/NCT04417270
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267
NCT04420247 Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 https://ClinicalTrials.gov/show/NCT04420247
NCT04413968 COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants https://ClinicalTrials.gov/show/NCT04413968
NCT04426305 Community Health Workers Against COVID19 https://ClinicalTrials.gov/show/NCT04426305
NCT04425616 SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer https://ClinicalTrials.gov/show/NCT04425616
NCT04421404 Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients https://ClinicalTrials.gov/show/NCT04421404
NCT04416334 PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 70 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS https://ClinicalTrials.gov/show/NCT04416334
NCT04453852 Monovalent Recombinant COVID19 Vaccine https://ClinicalTrials.gov/show/NCT04453852
NCT04418518 A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness https://ClinicalTrials.gov/show/NCT04418518
NCT04416399 STerOids in COVID-19 Study https://ClinicalTrials.gov/show/NCT04416399
NCT04435808 Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 https://ClinicalTrials.gov/show/NCT04435808
NCT04424212 ICBT for Mental Health Problems Related to the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04424212
NCT04421391 QuadraMune(TM) for Prevention of COVID-19 https://ClinicalTrials.gov/show/NCT04421391
NCT04420741 Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT04420741
NCT04422613 Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04422613
NCT04421664 Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) https://ClinicalTrials.gov/show/NCT04421664
NCT04420806 Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women https://ClinicalTrials.gov/show/NCT04420806
NCT04420338 SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study https://ClinicalTrials.gov/show/NCT04420338
NCT04420299 Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 https://ClinicalTrials.gov/show/NCT04420299
NCT04427566 Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise https://ClinicalTrials.gov/show/NCT04427566
NCT04424797 Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol https://ClinicalTrials.gov/show/NCT04424797
NCT04421508 A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 https://ClinicalTrials.gov/show/NCT04421508
NCT04421027 A Study of Baricitinib (LY3009104) in Participants With COVID-19 https://ClinicalTrials.gov/show/NCT04421027
NCT04441918 Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects https://ClinicalTrials.gov/show/NCT04441918
NCT04423289 Telematic Monitoring Through a Mobile Application of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423289
NCT04422561 Prophylactic Ivermectin in COVID-19 Contacts https://ClinicalTrials.gov/show/NCT04422561
NCT04425915 Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425915
NCT04424082 External Dead Space in Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424082
NCT04422353 Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease https://ClinicalTrials.gov/show/NCT04422353
NCT04425707 Ivermectin In Treatment of COVID 19 Patients https://ClinicalTrials.gov/show/NCT04425707
NCT04426292 SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04426292
NCT04425538 A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). https://ClinicalTrials.gov/show/NCT04425538
NCT04425005 Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric https://ClinicalTrials.gov/show/NCT04425005
NCT04423991 Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning https://ClinicalTrials.gov/show/NCT04423991
NCT04426695 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04426695
NCT04425629 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425629
NCT04475601 Enzalutamide Treatment in COVID-19 https://ClinicalTrials.gov/show/NCT04475601
NCT04445246 Inhaled Iloprost for Suspected COVID-19 Respiratory Failure https://ClinicalTrials.gov/show/NCT04445246
NCT04434131 Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04434131
NCT04429854 Donated Antibodies Working Against nCoV https://ClinicalTrials.gov/show/NCT04429854
NCT04428099 Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression https://ClinicalTrials.gov/show/NCT04428099
NCT04426318 COVID-19 and the Healthy Minds Program for Educators https://ClinicalTrials.gov/show/NCT04426318
NCT04458948 Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients https://ClinicalTrials.gov/show/NCT04458948
NCT04427501 A Study of LY3819253 (LY-CoV555) in Participants With Early Mild to Moderate COVID-19 Illness https://ClinicalTrials.gov/show/NCT04427501
NCT04425252 Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425252
NCT04429867 Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease https://ClinicalTrials.gov/show/NCT04429867
NCT04427137 Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04427137
NCT04435717 Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) https://ClinicalTrials.gov/show/NCT04435717
NCT04432051 The Use of Lung Ultrasonography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04432051
NCT04441424 Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04441424
NCT04433949 Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04433949
NCT04432298 Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease https://ClinicalTrials.gov/show/NCT04432298
NCT04431180 Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# https://ClinicalTrials.gov/show/NCT04431180
NCT04462757 SCIL-1Ra in COVID-19 Feasibility & PK/PD https://ClinicalTrials.gov/show/NCT04462757
NCT04431856 CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment https://ClinicalTrials.gov/show/NCT04431856
NCT04445272 Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04445272
NCT04434248 An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04434248
NCT04435353 Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 https://ClinicalTrials.gov/show/NCT04435353
NCT04432987 Dornase Alpha for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04432987
NCT04432805 Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 https://ClinicalTrials.gov/show/NCT04432805
NCT04444674 COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection https://ClinicalTrials.gov/show/NCT04444674
NCT04438694 Use of Convalescent Plasma for Treatment of Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04438694
NCT04449718 Vitamin D Supplementation in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04449718
NCT04445194 Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine https://ClinicalTrials.gov/show/NCT04445194
NCT04437875 An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04437875
NCT04436471 An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 https://ClinicalTrials.gov/show/NCT04436471
NCT04435379 Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04435379
NCT04435184 Crizanlizumab for Treating COVID-19 Vasculopathy https://ClinicalTrials.gov/show/NCT04435184
NCT04438070 COVID Screening Strategies in Homeless Shelters https://ClinicalTrials.gov/show/NCT04438070
NCT04437823 Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04437823
NCT04442958 Effectiveness of Convalescent Immune Plasma Therapy https://ClinicalTrials.gov/show/NCT04442958
NCT04444596 Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04444596
NCT04443881 Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) https://ClinicalTrials.gov/show/NCT04443881
NCT04443673 Glycine Supplement for Severe COVID-19 https://ClinicalTrials.gov/show/NCT04443673
NCT04441632 Effect of Positive Attitudes on Behavior and Wellness https://ClinicalTrials.gov/show/NCT04441632
NCT04438980 Glucocorticoids in COVID-19 (CORTIVID) https://ClinicalTrials.gov/show/NCT04438980
NCT04449276 A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults https://ClinicalTrials.gov/show/NCT04449276
NCT04441385 Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). https://ClinicalTrials.gov/show/NCT04441385
NCT04450004 Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. https://ClinicalTrials.gov/show/NCT04450004
NCT04445454 Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection https://ClinicalTrials.gov/show/NCT04445454
NCT04445389 Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04445389
NCT04445311 Ivermectin in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04445311
NCT04442152 Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants https://ClinicalTrials.gov/show/NCT04442152
NCT04445597 Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19 https://ClinicalTrials.gov/show/NCT04445597
NCT04444700 A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04444700
NCT04445285 Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure https://ClinicalTrials.gov/show/NCT04445285
NCT04445376 Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. https://ClinicalTrials.gov/show/NCT04445376
NCT04473274 GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study https://ClinicalTrials.gov/show/NCT04473274
NCT04445428 OPV as Potential Protection Against COVID-19 https://ClinicalTrials.gov/show/NCT04445428
NCT04447534 Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04447534
NCT04447404 DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury https://ClinicalTrials.gov/show/NCT04447404
NCT04445935 Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial https://ClinicalTrials.gov/show/NCT04445935
NCT04456361 Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04456361
NCT04448769 Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) https://ClinicalTrials.gov/show/NCT04448769
NCT04446377 A Study of LAM-002A for the Prevention of Progression of COVID-19 https://ClinicalTrials.gov/show/NCT04446377
NCT04458363 Convalescent Plasma in Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04458363
NCT04452773 Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04452773
NCT04449588 Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS https://ClinicalTrials.gov/show/NCT04449588
NCT04454606 The New Silicone N99 Half-Piece Respirator https://ClinicalTrials.gov/show/NCT04454606
NCT04464486 Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic https://ClinicalTrials.gov/show/NCT04464486
NCT04452565 NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04452565
NCT04451174 Early Use of Corticosteroids in Hospitalized Patients With Moderate COVID19 Pneumonia https://ClinicalTrials.gov/show/NCT04451174
NCT04463264 Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04463264
NCT04452435 Safety and Efficacy of C21 in Subjects With COVID-19 https://ClinicalTrials.gov/show/NCT04452435
NCT04451889 Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04451889
NCT04458298 A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients https://ClinicalTrials.gov/show/NCT04458298
NCT04457388 Tele-Yoga Therapy for Chronic Pain https://ClinicalTrials.gov/show/NCT04457388
NCT04460027 W-SUDs for COVID-19 https://ClinicalTrials.gov/show/NCT04460027
NCT04458246 Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04458246
NCT04461925 Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs https://ClinicalTrials.gov/show/NCT04461925
NCT04460534 Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) https://ClinicalTrials.gov/show/NCT04460534
NCT04457726 Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04457726
NCT04463849 Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients https://ClinicalTrials.gov/show/NCT04463849
NCT04465604 Hypertonic Saline for COVID-19 Symptoms https://ClinicalTrials.gov/show/NCT04465604
NCT04459247 Short Term, High Dose Vitamin D Supplementation for COVID-19 https://ClinicalTrials.gov/show/NCT04459247
NCT04459962 Covid-19 Breath Test https://ClinicalTrials.gov/show/NCT04459962
NCT04459325 Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04459325
NCT04466540 Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04466540
NCT04470869 Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. https://ClinicalTrials.gov/show/NCT04470869
NCT04467918 CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms https://ClinicalTrials.gov/show/NCT04467918
NCT04463420 Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04463420
NCT04468139 The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 https://ClinicalTrials.gov/show/NCT04468139
NCT04472728 Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04472728
NCT04462627 Reduction of COVID 19 Transmission to Health Care Professionals https://ClinicalTrials.gov/show/NCT04462627
NCT04464395 Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04464395
NCT04463004 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation https://ClinicalTrials.gov/show/NCT04463004
NCT04468646 To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04468646
NCT04466670 Hemostasis in COVID-19: an Adaptive Clinical Trial https://ClinicalTrials.gov/show/NCT04466670
NCT04463472 Study of COVID-19 DNA Vaccine (AG0301-COVID19) https://ClinicalTrials.gov/show/NCT04463472
NCT04466605 Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown https://ClinicalTrials.gov/show/NCT04466605
NCT04466280 Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04466280
NCT04473053 Rapid Experimental Medicine for COVID-19 https://ClinicalTrials.gov/show/NCT04473053
NCT04470999 Changes in Cellular Immune Profile During COVID-19 Infection https://ClinicalTrials.gov/show/NCT04470999
NCT04468009 Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma https://ClinicalTrials.gov/show/NCT04468009
NCT04465695 Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 https://ClinicalTrials.gov/show/NCT04465695
NCT04468893 Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 https://ClinicalTrials.gov/show/NCT04468893
NCT04470531 Role of Co-trimoxazole in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04470531
NCT04470739 Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? https://ClinicalTrials.gov/show/NCT04470739
NCT04470609 Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years https://ClinicalTrials.gov/show/NCT04470609
NCT04470622 Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) https://ClinicalTrials.gov/show/NCT04470622
NCT04475913 Digital vs Analog Impression in Cases of All-on-4 - Prosthesis https://ClinicalTrials.gov/show/NCT04475913
NCT04475107 The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients https://ClinicalTrials.gov/show/NCT04475107
NCT04473898 Telerehabilitation After Coronavirus https://ClinicalTrials.gov/show/NCT04473898
NCT04473261 Efficacy of Iodine Complex Against COVID-19 Patients https://ClinicalTrials.gov/show/NCT04473261
NCT04473248 Spartan COVID-19 System: Evaluation of Clinical Sample Collection https://ClinicalTrials.gov/show/NCT04473248
NCT04473170 Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 https://ClinicalTrials.gov/show/NCT04473170
NCT04472585 Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04472585
NCT04475575 Can the Electronic Nose Smell COVID-19 Antibodies? https://ClinicalTrials.gov/show/NCT04475575
NCT04475562 Can the Electronic Nose Smell COVID-19? https://ClinicalTrials.gov/show/NCT04475562
NCT04474340 COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients: Multicenter Interventional Study https://ClinicalTrials.gov/show/NCT04474340
NCT04475588 Efficacy and Safety of Itolizumab in COVID-19 Complications https://ClinicalTrials.gov/show/NCT04475588
NCT04475302 BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots https://ClinicalTrials.gov/show/NCT04475302
NCT04475120 Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients https://ClinicalTrials.gov/show/NCT04475120

Observational Studies

nct_id brief_title link
NCT04245631 Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV https://ClinicalTrials.gov/show/NCT04245631
NCT04256395 Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 https://ClinicalTrials.gov/show/NCT04256395
NCT04260308 A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04260308
NCT04255940 2019-nCoV Outbreak and Cardiovascular Diseases https://ClinicalTrials.gov/show/NCT04255940
NCT04259892 Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. https://ClinicalTrials.gov/show/NCT04259892
NCT04283396 Study for Novel Coronavirus Pneumonia (NCP) https://ClinicalTrials.gov/show/NCT04283396
NCT04279782 Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection https://ClinicalTrials.gov/show/NCT04279782
NCT04274322 Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool https://ClinicalTrials.gov/show/NCT04274322
NCT04275947 The COVID-19 Mobile Health Study (CMHS) https://ClinicalTrials.gov/show/NCT04275947
NCT04279899 The Investigation of the Neonates With or With Risk of COVID-19 https://ClinicalTrials.gov/show/NCT04279899
NCT04279795 Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations https://ClinicalTrials.gov/show/NCT04279795
NCT04282135 Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling https://ClinicalTrials.gov/show/NCT04282135
NCT04284046 CT Scores Predict Mortality in 2019-nCoV Pneumonia https://ClinicalTrials.gov/show/NCT04284046
NCT04292327 Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus https://ClinicalTrials.gov/show/NCT04292327
NCT04285801 Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study https://ClinicalTrials.gov/show/NCT04285801
NCT04292340 Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04292340
NCT04290780 COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04290780
NCT04306497 TCM Differentiation and Treatment Protocol of COVID-19 https://ClinicalTrials.gov/show/NCT04306497
NCT04292964 Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04292964
NCT04312464 Myocardial Damage in COVID-19 https://ClinicalTrials.gov/show/NCT04312464
NCT04302688 Accurate Classification System for Patients With COVID-19 Pneumonitis https://ClinicalTrials.gov/show/NCT04302688
NCT04306705 Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 https://ClinicalTrials.gov/show/NCT04306705
NCT04307459 Acute Respiratory Failure and COVID-19 in Real Life https://ClinicalTrials.gov/show/NCT04307459
NCT04316884 Mechanisms for Organ Dysfunction in Covid-19 https://ClinicalTrials.gov/show/NCT04316884
NCT04312100 Sequential Oxygen Therapy Strategy for Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04312100
NCT04319315 Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak https://ClinicalTrials.gov/show/NCT04319315
NCT04316299 Acute Kidney Injury in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04316299
NCT04314817 Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04314817
NCT04314232 Mechanisms for Covid-19 Disease Complications https://ClinicalTrials.gov/show/NCT04314232
NCT04313946 Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays https://ClinicalTrials.gov/show/NCT04313946
NCT04347369 A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease https://ClinicalTrials.gov/show/NCT04347369
NCT04321265 Outcomes and Prognostic Factors in COVID-19 https://ClinicalTrials.gov/show/NCT04321265
NCT04318366 COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor https://ClinicalTrials.gov/show/NCT04318366
NCT04316949 Predictors of Respiratory Failure in SARS-Cov-2 Infection https://ClinicalTrials.gov/show/NCT04316949
NCT04320017 Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04320017
NCT04318301 Hypertension in Patients Hospitalized With COVID-19 https://ClinicalTrials.gov/show/NCT04318301
NCT04319172 Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients https://ClinicalTrials.gov/show/NCT04319172
NCT04322513 Biomarkers for Identification of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04322513
NCT04322487 Simple, Safe, Same: Lung Ultrasound for COVID-19 https://ClinicalTrials.gov/show/NCT04322487
NCT04321369 Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals https://ClinicalTrials.gov/show/NCT04321369
NCT04320732 Risk Factors for Community- and Workplace Transmission of COVID-19 https://ClinicalTrials.gov/show/NCT04320732
NCT04320511 Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 https://ClinicalTrials.gov/show/NCT04320511
NCT04325919 Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong https://ClinicalTrials.gov/show/NCT04325919
NCT04323787 Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry https://ClinicalTrials.gov/show/NCT04323787
NCT04322279 Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. https://ClinicalTrials.gov/show/NCT04322279
NCT04322188 An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications https://ClinicalTrials.gov/show/NCT04322188
NCT04327180 PREdiction of DIagnosed Covid-19 infecTion in IUC Patients https://ClinicalTrials.gov/show/NCT04327180
NCT04324684 Prognostic Factors Keeping Track for COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04324684
NCT04324047 Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04324047
NCT04323644 Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) https://ClinicalTrials.gov/show/NCT04323644
NCT04324736 “COVID-19 and Diabetes Outcomes” https://ClinicalTrials.gov/show/NCT04324736
NCT04332913 Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia https://ClinicalTrials.gov/show/NCT04332913
NCT04327804 A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research https://ClinicalTrials.gov/show/NCT04327804
NCT04326725 Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04326725
NCT04326387 Evaluation of Novel Diagnostic Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04326387
NCT04325646 Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France https://ClinicalTrials.gov/show/NCT04325646
NCT04328454 Clinical Characteristics and Prognostic Factors of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04328454
NCT04327531 Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study https://ClinicalTrials.gov/show/NCT04327531
NCT04331106 Survey of the Anxiety Associated With the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04331106
NCT04329546 Understanding COVID-19 https://ClinicalTrials.gov/show/NCT04329546
NCT04336384 Impact of Covid-19 in Congenital Heart Disease https://ClinicalTrials.gov/show/NCT04336384
NCT04332016 COVID-19 Biological Samples Collection https://ClinicalTrials.gov/show/NCT04332016
NCT04330261 Clinical Characteristics and Outcomes of Pediatric COVID-19 https://ClinicalTrials.gov/show/NCT04330261
NCT04330521 Impact of the Coronavirus (COVID-19) on Patients With Cancer https://ClinicalTrials.gov/show/NCT04330521
NCT04337983 Hemodynamic Characteristics of Patients With SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337983
NCT04340219 Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04340219
NCT04335188 COVID-19 Registry Rhineland-Palatinate (Germany) https://ClinicalTrials.gov/show/NCT04335188
NCT04331886 An Observational Study of Patients With Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04331886
NCT04331509 COVID-19 Symptom Tracker https://ClinicalTrials.gov/show/NCT04331509
NCT04333862 Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy https://ClinicalTrials.gov/show/NCT04333862
NCT04333849 Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 https://ClinicalTrials.gov/show/NCT04333849
NCT04335630 Cardiovascular Manifestations of COVID-19 https://ClinicalTrials.gov/show/NCT04335630
NCT04336215 Rutgers COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04336215
NCT04334252 Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04334252
NCT04344925 Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19 https://ClinicalTrials.gov/show/NCT04344925
NCT04340921 The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury https://ClinicalTrials.gov/show/NCT04340921
NCT04337190 Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) https://ClinicalTrials.gov/show/NCT04337190
NCT04337151 Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment https://ClinicalTrials.gov/show/NCT04337151
NCT04337047 Distress in Crisis Situations During COVID-19 https://ClinicalTrials.gov/show/NCT04337047
NCT04336761 Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France https://ClinicalTrials.gov/show/NCT04336761
NCT04336657 Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? https://ClinicalTrials.gov/show/NCT04336657
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04335747
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc) https://ClinicalTrials.gov/show/NCT04335162
NCT04334954 SARS-COV2 Pandemic Serosurvey and Blood Sampling https://ClinicalTrials.gov/show/NCT04334954
NCT04342702 A Study on the Prospective Cohort Library of COVID-19 in Southeran https://ClinicalTrials.gov/show/NCT04342702
NCT04338672 The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients https://ClinicalTrials.gov/show/NCT04338672
NCT04337424 Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04337424
NCT04337320 Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study https://ClinicalTrials.gov/show/NCT04337320
NCT04366765 COVID-19 Survival - The COVIVA Study https://ClinicalTrials.gov/show/NCT04366765
NCT04346602 A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 https://ClinicalTrials.gov/show/NCT04346602
NCT04339998 Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) https://ClinicalTrials.gov/show/NCT04339998
NCT04339387 COVID-19 Risk Stratification https://ClinicalTrials.gov/show/NCT04339387
NCT04337762 Beat COVID-19 - Observational Trial https://ClinicalTrials.gov/show/NCT04337762
NCT04337502 Clinical and Radiomic Model of COVID-19 https://ClinicalTrials.gov/show/NCT04337502
NCT04347408 Seroprevalence of SARS-Cov-2 Antibodies in Children https://ClinicalTrials.gov/show/NCT04347408
NCT04343742 Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 https://ClinicalTrials.gov/show/NCT04343742
NCT04342637 COVID-19 Endoscopy Survey https://ClinicalTrials.gov/show/NCT04342637
NCT04339634 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy https://ClinicalTrials.gov/show/NCT04339634
NCT04339608 Max COVID19- Study https://ClinicalTrials.gov/show/NCT04339608
NCT04338945 Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy https://ClinicalTrials.gov/show/NCT04338945
NCT04338932 COVID-19 and Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04338932
NCT04347928 Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 https://ClinicalTrials.gov/show/NCT04347928
NCT04347460 Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH https://ClinicalTrials.gov/show/NCT04347460
NCT04343339 Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment https://ClinicalTrials.gov/show/NCT04343339
NCT04342884 COVID-19 Community Research Partnership https://ClinicalTrials.gov/show/NCT04342884
NCT04342104 NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure https://ClinicalTrials.gov/show/NCT04342104
NCT04341714 Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04341714
NCT04339686 Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. https://ClinicalTrials.gov/show/NCT04339686
NCT04343404 Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 https://ClinicalTrials.gov/show/NCT04343404
NCT04342195 Acquiring Convalescent Specimens for COVID-19 Antibodies https://ClinicalTrials.gov/show/NCT04342195
NCT04352634 The Covid-19 HEalth caRe wOrkErS (HEROES) Study https://ClinicalTrials.gov/show/NCT04352634
NCT04339790 Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers https://ClinicalTrials.gov/show/NCT04339790
NCT04358952 Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients https://ClinicalTrials.gov/show/NCT04358952
NCT04357847 Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04357847
NCT04352556 COVID19-hematological Malignancies: the Italian Hematology Alliance https://ClinicalTrials.gov/show/NCT04352556
NCT04350710 Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS https://ClinicalTrials.gov/show/NCT04350710
NCT04347824 Predict Adverse Events by Covid-19 Nephritis https://ClinicalTrials.gov/show/NCT04347824
NCT04344327 Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF https://ClinicalTrials.gov/show/NCT04344327
NCT04344197 Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey https://ClinicalTrials.gov/show/NCT04344197
NCT04344145 Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population https://ClinicalTrials.gov/show/NCT04344145
NCT04344119 Assessment of Chilbains Occuring During Covid-19 Infection https://ClinicalTrials.gov/show/NCT04344119
NCT04343898 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04343898
NCT04343781 National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 https://ClinicalTrials.gov/show/NCT04343781
NCT04346342 PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) https://ClinicalTrials.gov/show/NCT04346342
NCT04347850 A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04347850
NCT04381312 Direct and Indirect Impact of COVID-19 In Older Populations https://ClinicalTrials.gov/show/NCT04381312
NCT04352517 Influence Physical Activity Psychological Responses COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04352517
NCT04347070 Implementation of Physiotherapy on COVID-19 Patients in ICU https://ClinicalTrials.gov/show/NCT04347070
NCT04346212 Oropharyngeal Dysphagia in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04346212
NCT04345640 The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. https://ClinicalTrials.gov/show/NCT04345640
NCT04345315 Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. https://ClinicalTrials.gov/show/NCT04345315
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT04345159
NCT04344171 CovidDB: The Covid-19 Inpatient Database https://ClinicalTrials.gov/show/NCT04344171
NCT04346121 Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis https://ClinicalTrials.gov/show/NCT04346121
NCT04351711 Immunological Profiling of Patients With COVID-19 in Respiratory Distress https://ClinicalTrials.gov/show/NCT04351711
NCT04344964 Endoscopy-related Phone Consultation During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04344964
NCT04347694 Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. https://ClinicalTrials.gov/show/NCT04347694
NCT04353934 The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic https://ClinicalTrials.gov/show/NCT04353934
NCT04373889 COVID-19 Among Healthcare Workers in Belgian Hospitals https://ClinicalTrials.gov/show/NCT04373889
NCT04356560 COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department https://ClinicalTrials.gov/show/NCT04356560
NCT04354584 Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04354584
NCT04352582 COVID-19 and Vaccination Attitudes https://ClinicalTrials.gov/show/NCT04352582
NCT04349163 Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. https://ClinicalTrials.gov/show/NCT04349163
NCT04349202 Beaumont Health Large-scale Automated Serologic Testing for COVID-19 https://ClinicalTrials.gov/show/NCT04349202
NCT04348214 Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals https://ClinicalTrials.gov/show/NCT04348214
NCT04346264 CoVid-19 - Infection and Antibody Formation in the Viennese Population https://ClinicalTrials.gov/show/NCT04346264
NCT04346056 Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 https://ClinicalTrials.gov/show/NCT04346056
NCT04348552 Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study https://ClinicalTrials.gov/show/NCT04348552
NCT04344977 Collection of Anti-SARS-CoV-2 Immune Plasma https://ClinicalTrials.gov/show/NCT04344977
NCT04386369 Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS https://ClinicalTrials.gov/show/NCT04386369
NCT04352699 Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? https://ClinicalTrials.gov/show/NCT04352699
NCT04352491 An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease https://ClinicalTrials.gov/show/NCT04352491
NCT04351568 Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; https://ClinicalTrials.gov/show/NCT04351568
NCT04351399 Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351399
NCT04350073 Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) https://ClinicalTrials.gov/show/NCT04350073
NCT04349540 Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 https://ClinicalTrials.gov/show/NCT04349540
NCT04347876 Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? https://ClinicalTrials.gov/show/NCT04347876
NCT04386109 Neonatal Complications of Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04386109
NCT04353609 Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases https://ClinicalTrials.gov/show/NCT04353609
NCT04353401 WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS https://ClinicalTrials.gov/show/NCT04353401
NCT04353011 Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04353011
NCT04351633 Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04351633
NCT04351503 A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 https://ClinicalTrials.gov/show/NCT04351503
NCT04351139 Impact of the COVID-19 Pandemic in Gynecological Oncology https://ClinicalTrials.gov/show/NCT04351139
NCT04355741 Gut Microbiota, “Spark and Flame” of COVID-19 Disease https://ClinicalTrials.gov/show/NCT04355741
NCT04348240 Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions https://ClinicalTrials.gov/show/NCT04348240
NCT04376905 Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04376905
NCT04373109 Stroke Rehabilitation Outcome During COVID-19 Lockdown https://ClinicalTrials.gov/show/NCT04373109
NCT04367129 Electrocardiogram Analysis in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04367129
NCT04366154 Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers https://ClinicalTrials.gov/show/NCT04366154
NCT04360538 Long Term Outcomes of Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360538
NCT04357769 COVID-19 Pandemic Burden in Severe Mental Disease Patients https://ClinicalTrials.gov/show/NCT04357769
NCT04357418 Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives https://ClinicalTrials.gov/show/NCT04357418
NCT04356443 Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection https://ClinicalTrials.gov/show/NCT04356443
NCT04355442 Evolution of Facial Trauma During COVID Containment Measures https://ClinicalTrials.gov/show/NCT04355442
NCT04354792 Asymptomatic COVID-19 Infection Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04354792
NCT04353141 International Lung UltraSound Analysis (ILUSA) Study https://ClinicalTrials.gov/show/NCT04353141
NCT04352842 Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19) https://ClinicalTrials.gov/show/NCT04352842
NCT04356950 Analysis of the Coagulopathy Developed by COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04356950
NCT04351659 Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04351659
NCT04367402 COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) https://ClinicalTrials.gov/show/NCT04367402
NCT04367363 Social Media and COVID-19 https://ClinicalTrials.gov/show/NCT04367363
NCT04366921 European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO https://ClinicalTrials.gov/show/NCT04366921
NCT04361786 Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection https://ClinicalTrials.gov/show/NCT04361786
NCT04357041 COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being https://ClinicalTrials.gov/show/NCT04357041
NCT04356378 Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation https://ClinicalTrials.gov/show/NCT04356378
NCT04355715 Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia https://ClinicalTrials.gov/show/NCT04355715
NCT04355702 Covid-19 in Lupus Patients https://ClinicalTrials.gov/show/NCT04355702
NCT04355624 Kidney Involvement in COVID-19 Disease (COVKID) https://ClinicalTrials.gov/show/NCT04355624
NCT04355611 Epidemiological Characteristics of COVID-19 in Patients With MS or NMO https://ClinicalTrials.gov/show/NCT04355611
NCT04355481 Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT04355481
NCT04354857 Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection https://ClinicalTrials.gov/show/NCT04354857
NCT04354779 Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. https://ClinicalTrials.gov/show/NCT04354779
NCT04354766 COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04354766
NCT04354753 AiM COVID for Covid 19 Tracking and Prediction https://ClinicalTrials.gov/show/NCT04354753
NCT04358380 Liver Injury in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04358380
NCT04365166 Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365166
NCT04363333 Obstructive Sleep Apnea & Covid-19 Outcomes https://ClinicalTrials.gov/show/NCT04363333
NCT04359914 Neurocognitive Impairment in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04359914
NCT04356885 COVID-19 and Psychotic Symptoms in France https://ClinicalTrials.gov/show/NCT04356885
NCT04355871 Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain https://ClinicalTrials.gov/show/NCT04355871
NCT04357535 Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives https://ClinicalTrials.gov/show/NCT04357535
NCT04385069 COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study https://ClinicalTrials.gov/show/NCT04385069
NCT04384029 The Geneva Covid-19 CVD Study https://ClinicalTrials.gov/show/NCT04384029
NCT04376853 CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch https://ClinicalTrials.gov/show/NCT04376853
NCT04374123 COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit https://ClinicalTrials.gov/show/NCT04374123
NCT04362345 Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04362345
NCT04361877 Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) https://ClinicalTrials.gov/show/NCT04361877
NCT04360954 Evaluation of Antibody Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04360954
NCT04359849 Sequencing and Tracking of Phylogeny in COVID-19 Study https://ClinicalTrials.gov/show/NCT04359849
NCT04359836 A Study to Explore the Role of Gut Flora in COVID-19 Infection https://ClinicalTrials.gov/show/NCT04359836
NCT04359407 Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients https://ClinicalTrials.gov/show/NCT04359407
NCT04358536 Classification of COVID-19 Infection in Posteroanterior Chest X-rays https://ClinicalTrials.gov/show/NCT04358536
NCT04358510 COVID-19 Mortality Prediction Model https://ClinicalTrials.gov/show/NCT04358510
NCT04358029 Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04358029
NCT04357938 Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04357938
NCT04357574 Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 https://ClinicalTrials.gov/show/NCT04357574
NCT04403009 The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04403009
NCT04397835 Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population https://ClinicalTrials.gov/show/NCT04397835
NCT04375748 Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases https://ClinicalTrials.gov/show/NCT04375748
NCT04365959 The Prone Position in Covid-19 Affected Patients https://ClinicalTrials.gov/show/NCT04365959
NCT04363008 COVID 19 Biomarkers https://ClinicalTrials.gov/show/NCT04363008
NCT04360850 Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04360850
NCT04359693 Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections https://ClinicalTrials.gov/show/NCT04359693
NCT04359121 COVID-19 and the Developement of Phobic Fears of Disease https://ClinicalTrials.gov/show/NCT04359121
NCT04358640 Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey https://ClinicalTrials.gov/show/NCT04358640
NCT04356365 The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) https://ClinicalTrials.gov/show/NCT04356365
NCT04357431 COVID-19 Among Egyptian Health Care Providers https://ClinicalTrials.gov/show/NCT04357431
NCT04366024 A Novel Nomogram to Predict Severity of COVID-19 https://ClinicalTrials.gov/show/NCT04366024
NCT04393233 Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation https://ClinicalTrials.gov/show/NCT04393233
NCT04371848 Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study https://ClinicalTrials.gov/show/NCT04371848
NCT04369807 Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04369807
NCT04366934 Study of the Pathogenesis of Olfactory Disorders in COVID-19 https://ClinicalTrials.gov/show/NCT04366934
NCT04362995 St. Jude Tracking of Viral and Host Factors Associated With COVID-19 https://ClinicalTrials.gov/show/NCT04362995
NCT04362943 Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults https://ClinicalTrials.gov/show/NCT04362943
NCT04361565 Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04361565
NCT04361019 Physical Activity in University Students Around COVID-19 Confinement https://ClinicalTrials.gov/show/NCT04361019
NCT04360863 The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong https://ClinicalTrials.gov/show/NCT04360863
NCT04360733 Precision Immunology to Determine the Immune Response in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04360733
NCT04360707 Solid Organ Transplant Recipients With SARS-CoV-2 French Registry https://ClinicalTrials.gov/show/NCT04360707
NCT04360278 Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04360278
NCT04371250 Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. https://ClinicalTrials.gov/show/NCT04371250
NCT04361123 Atrium COVID-19 Syndromic and Serologic Surveillance https://ClinicalTrials.gov/show/NCT04361123
NCT04396600 The Professional Peer Resilience Initiative https://ClinicalTrials.gov/show/NCT04396600
NCT04381286 Transpulmonary Driving Pressure in ARDS COVID19 Patients https://ClinicalTrials.gov/show/NCT04381286
NCT04366778 Thrombosis and Covid-19 https://ClinicalTrials.gov/show/NCT04366778
NCT04363788 Needle Stick Injuries in Emergency Medical Service Practice https://ClinicalTrials.gov/show/NCT04363788
NCT04363268 ACCESS A Master Digital Surveillance Protocol for COVID-19 https://ClinicalTrials.gov/show/NCT04363268
NCT04363099 Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. https://ClinicalTrials.gov/show/NCT04363099
NCT04362319 Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04362319
NCT04362150 Long-term Impact of Infection With Novel Coronavirus (COVID-19) https://ClinicalTrials.gov/show/NCT04362150
NCT04368793 Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge https://ClinicalTrials.gov/show/NCT04368793
NCT04377815 Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste https://ClinicalTrials.gov/show/NCT04377815
NCT04370678 Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures https://ClinicalTrials.gov/show/NCT04370678
NCT04366167 Patient Recovery From Heart Surgery During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04366167
NCT04365595 SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) https://ClinicalTrials.gov/show/NCT04365595
NCT04365335 Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04365335
NCT04364698 Observational Cohort of COVID-19 Patients at Raymond-Poincare https://ClinicalTrials.gov/show/NCT04364698
NCT04362930 Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) https://ClinicalTrials.gov/show/NCT04362930
NCT04371315 Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children https://ClinicalTrials.gov/show/NCT04371315
NCT04362865 Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection https://ClinicalTrials.gov/show/NCT04362865
NCT04365764 Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study https://ClinicalTrials.gov/show/NCT04365764
NCT04365725 Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections https://ClinicalTrials.gov/show/NCT04365725
NCT04365634 A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. https://ClinicalTrials.gov/show/NCT04365634
NCT04365361 The Psychological Impact of the COVID-19 on Students. https://ClinicalTrials.gov/show/NCT04365361
NCT04365348 The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families https://ClinicalTrials.gov/show/NCT04365348
NCT04382534 A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction https://ClinicalTrials.gov/show/NCT04382534
NCT04373811 One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting https://ClinicalTrials.gov/show/NCT04373811
NCT04368637 Acute Cardiovascular Events Triggered by COVID-19-Related Stress https://ClinicalTrials.gov/show/NCT04368637
NCT04365881 Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology https://ClinicalTrials.gov/show/NCT04365881
NCT04365530 Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City https://ClinicalTrials.gov/show/NCT04365530
NCT04367064 To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) https://ClinicalTrials.gov/show/NCT04367064
NCT04383470 Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383470
NCT04367896 COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY https://ClinicalTrials.gov/show/NCT04367896
NCT04368351 Bacteriotherapy in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04368351
NCT04368026 SARS-CoV-2 and Surgery https://ClinicalTrials.gov/show/NCT04368026
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04367805
NCT04367792 Cardiac Injury in COVID-19: a Pathology Study https://ClinicalTrials.gov/show/NCT04367792
NCT04367740 ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04367740
NCT04366752 Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04366752
NCT04368897 In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity https://ClinicalTrials.gov/show/NCT04368897
NCT04375670 COVID19-FOIE National Observatory https://ClinicalTrials.gov/show/NCT04375670
NCT04371354 Outcomes of Covid-19 Protective Measures in Endoscopy https://ClinicalTrials.gov/show/NCT04371354
NCT04370249 Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 https://ClinicalTrials.gov/show/NCT04370249
NCT04369989 Observational Study of COVID-19 Treatment Efficacy https://ClinicalTrials.gov/show/NCT04369989
NCT04368390 Neuroradiolological Analysis of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368390
NCT04368338 Lung Ultrasound to Diagnose COVID-19 https://ClinicalTrials.gov/show/NCT04368338
NCT04367883 Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection https://ClinicalTrials.gov/show/NCT04367883
NCT04367870 COVID-19 Detection Test in Oncology https://ClinicalTrials.gov/show/NCT04367870
NCT04367337 Health Behavior Change During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04367337
NCT04385212 Outcomes in Hospitalized Older Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04385212
NCT04374422 COVID-19 Pandemic and Female Sexual Behavior https://ClinicalTrials.gov/show/NCT04374422
NCT04372576 Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04372576
NCT04372472 SQuISH-COVID: A Pilot Study https://ClinicalTrials.gov/show/NCT04372472
NCT04372056 The COVID-ICU Healthcare Professional Study https://ClinicalTrials.gov/show/NCT04372056
NCT04370275 Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia https://ClinicalTrials.gov/show/NCT04370275
NCT04370197 Covid-19 Epidemic on Acute Stroke Management https://ClinicalTrials.gov/show/NCT04370197
NCT04370119 Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers https://ClinicalTrials.gov/show/NCT04370119
NCT04369859 Obstetric and Perinatal Outcomes of Women With COVID-19 https://ClinicalTrials.gov/show/NCT04369859
NCT04368884 Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04368884
NCT04368871 Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study https://ClinicalTrials.gov/show/NCT04368871
NCT04370210 Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry https://ClinicalTrials.gov/show/NCT04370210
NCT04371432 Genetics of COVID-19 Susceptibility and Manifestations https://ClinicalTrials.gov/show/NCT04371432
NCT04380987 Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis https://ClinicalTrials.gov/show/NCT04380987
NCT04379089 Neurologic Manifestations of COVID 19 in Children https://ClinicalTrials.gov/show/NCT04379089
NCT04376580 Use of the Nasal Cannula During COVID-19 https://ClinicalTrials.gov/show/NCT04376580
NCT04375410 Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04375410
NCT04374071 Early Short Course Corticosteroids in COVID-19 https://ClinicalTrials.gov/show/NCT04374071
NCT04373486 Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels https://ClinicalTrials.gov/show/NCT04373486
NCT04371679 Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04371679
NCT04371562 Predicting Death and ICU Admission in COVID-19 Patients in ED https://ClinicalTrials.gov/show/NCT04371562
NCT04371471 Covid-19 Pandemic Triage Score https://ClinicalTrials.gov/show/NCT04371471
NCT04375761 COVID-19: Human Epidemiology and Response to SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04375761
NCT04373148 Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 https://ClinicalTrials.gov/show/NCT04373148
NCT04377581 COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior https://ClinicalTrials.gov/show/NCT04377581
NCT04384471 Covid-19 Pandemic: Patients’ Experience in T1D https://ClinicalTrials.gov/show/NCT04384471
NCT04377035 The Role of Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04377035
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374656
NCT04374058 Less Frequency Hemodialysis and COVID-19 https://ClinicalTrials.gov/show/NCT04374058
NCT04373798 C-reactive Protein Levels Among Individuals With COVID-19 https://ClinicalTrials.gov/show/NCT04373798
NCT04378777 Immunophenotyping Assessment in a COVID-19 Cohort https://ClinicalTrials.gov/show/NCT04378777
NCT04377412 Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04377412
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617
NCT04374513 Community Pharmacists Behaviour During Covid-19 https://ClinicalTrials.gov/show/NCT04374513
NCT04374097 Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04374097
NCT04375176 Monocytes and NK Cells Activity in Covid-19 Patients https://ClinicalTrials.gov/show/NCT04375176
NCT04375137 Correlation Between Oxidative Stress Status and COVID-19 Severity https://ClinicalTrials.gov/show/NCT04375137
NCT04382417 Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden https://ClinicalTrials.gov/show/NCT04382417
NCT04381819 Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 https://ClinicalTrials.gov/show/NCT04381819
NCT04380896 COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) https://ClinicalTrials.gov/show/NCT04380896
NCT04379310 Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) https://ClinicalTrials.gov/show/NCT04379310
NCT04379245 COVID-19 Infection in Patients Infected With HIV and/or on PrEP https://ClinicalTrials.gov/show/NCT04379245
NCT04379232 Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center https://ClinicalTrials.gov/show/NCT04379232
NCT04377607 Haemoglobin Concentration on COVID-19 https://ClinicalTrials.gov/show/NCT04377607
NCT04377074 Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety https://ClinicalTrials.gov/show/NCT04377074
NCT04376996 Slovenian National COVID-19 Prevalence Study https://ClinicalTrials.gov/show/NCT04376996
NCT04376944 Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation https://ClinicalTrials.gov/show/NCT04376944
NCT04376879 Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) https://ClinicalTrials.gov/show/NCT04376879
NCT04376775 Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation https://ClinicalTrials.gov/show/NCT04376775
NCT04375709 Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); https://ClinicalTrials.gov/show/NCT04375709
NCT04375501 A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04375501
NCT04379284 Risks of COVID19 in the Pregnant Population https://ClinicalTrials.gov/show/NCT04379284
NCT04388813 Predictors of Severe COVID-19 Outcomes https://ClinicalTrials.gov/show/NCT04388813
NCT04410718 Glycaemia and Cardiac Function in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04410718
NCT04382469 Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT https://ClinicalTrials.gov/show/NCT04382469
NCT04382235 Non-invasive Ventilatory Support of Patients Affected by COVID-19 https://ClinicalTrials.gov/show/NCT04382235
NCT04380870 Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 https://ClinicalTrials.gov/show/NCT04380870
NCT04379063 COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress https://ClinicalTrials.gov/show/NCT04379063
NCT04378842 COVID-19 and ICU-acquired MDR Bacteria https://ClinicalTrials.gov/show/NCT04378842
NCT04378686 Serological Testing for COVID-19 (SARS-CoV-2) in ESKD https://ClinicalTrials.gov/show/NCT04378686
NCT04378595 Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin https://ClinicalTrials.gov/show/NCT04378595
NCT04378582 Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU https://ClinicalTrials.gov/show/NCT04378582
NCT04377776 Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients https://ClinicalTrials.gov/show/NCT04377776
NCT04377685 Prediction of Clinical Course in COVID19 Patients https://ClinicalTrials.gov/show/NCT04377685
NCT04377490 Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04377490
NCT04378881 Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations https://ClinicalTrials.gov/show/NCT04378881
NCT04377724 Spread and Course of COVID-19 Infections https://ClinicalTrials.gov/show/NCT04377724
NCT04416347 COVID19 Clinical Predictors and Outcome https://ClinicalTrials.gov/show/NCT04416347
NCT04393155 Longitudinal COVID-19 Cohort Study https://ClinicalTrials.gov/show/NCT04393155
NCT04386395 Immune Changes in Severe COVID-19 Pulmonary Infections https://ClinicalTrials.gov/show/NCT04386395
NCT04382781 Immunosupressive Treatment in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04382781
NCT04382508 Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. https://ClinicalTrials.gov/show/NCT04382508
NCT04381273 Oral Health and Psychosocial Factors During the Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04381273
NCT04379297 COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) https://ClinicalTrials.gov/show/NCT04379297
NCT04384705 HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital https://ClinicalTrials.gov/show/NCT04384705
NCT04383899 Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019 https://ClinicalTrials.gov/show/NCT04383899
NCT04383678 Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04383678
NCT04383652 Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales https://ClinicalTrials.gov/show/NCT04383652
NCT04383483 CoV-ICU Score, Intensive Care Unit, SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04383483
NCT04381351 Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction https://ClinicalTrials.gov/show/NCT04381351
NCT04380792 Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital https://ClinicalTrials.gov/show/NCT04380792
NCT04380779 Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses https://ClinicalTrials.gov/show/NCT04380779
NCT04380714 Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 https://ClinicalTrials.gov/show/NCT04380714
NCT04385004 Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU https://ClinicalTrials.gov/show/NCT04385004
NCT04384055 Predicting Outcomes for Covid-19 Using Sonography https://ClinicalTrials.gov/show/NCT04384055
NCT04383886 Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383886
NCT04382495 The Impact of COVID-19 Pandemic on Cancer Care https://ClinicalTrials.gov/show/NCT04382495
NCT04382196 Impact of COVID-19 on Mental Health of Health Care Workers https://ClinicalTrials.gov/show/NCT04382196
NCT04383730 Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) https://ClinicalTrials.gov/show/NCT04383730
NCT04382794 Sitagliptin Treatment in Diabetic COVID-19 Positive Patients https://ClinicalTrials.gov/show/NCT04382794
NCT04383444 Surveillance of Individuals Following SARS-CoV-2 Exposure https://ClinicalTrials.gov/show/NCT04383444
NCT04385238 Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04385238
NCT04384250 Genetic Basis of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04384250
NCT04383626 Fear Among Dentists During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04383626
NCT04431310 Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04431310
NCT04409535 Effects of the COVID-19 Health Emergency on Biopsychosocial Health https://ClinicalTrials.gov/show/NCT04409535
NCT04389320 Antimalarial and Covid 19 in Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04389320
NCT04387786 Dornase Alfa Administered to Patients With COVID-19 (DACOVID) https://ClinicalTrials.gov/show/NCT04387786
NCT04386720 Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. https://ClinicalTrials.gov/show/NCT04386720
NCT04386551 Detection of COVID-19 in Saliva Collection https://ClinicalTrials.gov/show/NCT04386551
NCT04385823 Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04385823
NCT04385160 Myeloproliferative Neoplasms (MPN) and COVID-19 https://ClinicalTrials.gov/show/NCT04385160
NCT04384926 Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis https://ClinicalTrials.gov/show/NCT04384926
NCT04384887 “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” https://ClinicalTrials.gov/show/NCT04384887
NCT04385147 Advanced Endoscopy During COVID-19 https://ClinicalTrials.gov/show/NCT04385147
NCT04388670 Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04388670
NCT04388579 Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 https://ClinicalTrials.gov/show/NCT04388579
NCT04387279 The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04387279
NCT04386460 Covid-19 and Prevention of Malnutrition After Confinement by Dentists https://ClinicalTrials.gov/show/NCT04386460
NCT04387214 COVID-19 Pandemic and Academic Performance of Veterinary Students https://ClinicalTrials.gov/show/NCT04387214
NCT04392401 COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study https://ClinicalTrials.gov/show/NCT04392401
NCT04389645 Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04389645
NCT04389567 Famotidine Outpatient COVID-19 Treatment Study https://ClinicalTrials.gov/show/NCT04389567
NCT04388657 COVID-19, bLOod Coagulation and Thrombosis https://ClinicalTrials.gov/show/NCT04388657
NCT04387838 Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff https://ClinicalTrials.gov/show/NCT04387838
NCT04387799 Determinants of COVID-19 Pneumonia (MC-19) https://ClinicalTrials.gov/show/NCT04387799
NCT04387643 Protecting Health Care Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04387643
NCT04406324 COVID-19: Respiratory and Sleep Follow-up https://ClinicalTrials.gov/show/NCT04406324
NCT04388618 Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia https://ClinicalTrials.gov/show/NCT04388618
NCT04387656 NCI COVID-19 in Cancer Patients, NCCAPS Study https://ClinicalTrials.gov/show/NCT04387656
NCT04410835 Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders https://ClinicalTrials.gov/show/NCT04410835
NCT04393428 Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04393428
NCT04392089 Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS https://ClinicalTrials.gov/show/NCT04392089
NCT04391738 Association Between BMI and COVID-19 https://ClinicalTrials.gov/show/NCT04391738
NCT04390126 COVID-19 Related Lockdown Effects On Chronic Diseases https://ClinicalTrials.gov/show/NCT04390126
NCT04389658 Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) https://ClinicalTrials.gov/show/NCT04389658
NCT04389515 Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04389515
NCT04389489 Postpartum Sexual Function in Pregnant Women With COVID-19 https://ClinicalTrials.gov/show/NCT04389489
NCT04389463 Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04389463
NCT04391881 Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population https://ClinicalTrials.gov/show/NCT04391881
NCT04389684 Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors https://ClinicalTrials.gov/show/NCT04389684
NCT04395833 National Survey on the Lockdown of Children With Disabilities https://ClinicalTrials.gov/show/NCT04395833
NCT04394026 Imaging Feature of SARS-CoV2 Infection https://ClinicalTrials.gov/show/NCT04394026
NCT04393402 Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) https://ClinicalTrials.gov/show/NCT04393402
NCT04392388 Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis https://ClinicalTrials.gov/show/NCT04392388
NCT04392245 Proctologic Practice and Covid-19 https://ClinicalTrials.gov/show/NCT04392245
NCT04391166 Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04391166
NCT04453670 Neuropathology in Adults Intensive Care Unit Patients With COVID 19 https://ClinicalTrials.gov/show/NCT04453670
NCT04391816 COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study https://ClinicalTrials.gov/show/NCT04391816
NCT04394195 sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? https://ClinicalTrials.gov/show/NCT04394195
NCT04393558 Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms https://ClinicalTrials.gov/show/NCT04393558
NCT04396197 Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care https://ClinicalTrials.gov/show/NCT04396197
NCT04414319 Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly https://ClinicalTrials.gov/show/NCT04414319
NCT04410263 Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches https://ClinicalTrials.gov/show/NCT04410263
NCT04409197 Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network https://ClinicalTrials.gov/show/NCT04409197
NCT04401241 How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department https://ClinicalTrials.gov/show/NCT04401241
NCT04396353 EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04396353
NCT04396210 Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04396210
NCT04395859 Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents https://ClinicalTrials.gov/show/NCT04395859
NCT04395482 Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury https://ClinicalTrials.gov/show/NCT04395482
NCT04394429 Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04394429
NCT04394078 Impact of COVID-19 Pandemic on Depression and Quality of Life https://ClinicalTrials.gov/show/NCT04394078
NCT04393974 COVID-19 and Cancer Patients https://ClinicalTrials.gov/show/NCT04393974
NCT04397939 Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04397939
NCT04397900 Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes https://ClinicalTrials.gov/show/NCT04397900
NCT04397848 Mental Health Outcomes in Healthcare Workers During COVID-19 https://ClinicalTrials.gov/show/NCT04397848
NCT04397822 COVID-19: Study of INFLAmmasome and PLAtelets Functions https://ClinicalTrials.gov/show/NCT04397822
NCT04397588 Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 https://ClinicalTrials.gov/show/NCT04397588
NCT04395924 Maternal-foetal Transmission of SARS-Cov-2 https://ClinicalTrials.gov/show/NCT04395924
NCT04395755 Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed https://ClinicalTrials.gov/show/NCT04395755
NCT04395664 Arrhythmias in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04395664
NCT04395391 Home Usability Study of the SARS-CoV-2 (COVID-19) Test https://ClinicalTrials.gov/show/NCT04395391
NCT04395300 Sleep Quality in Healthcare Personnel During COVID-19 https://ClinicalTrials.gov/show/NCT04395300
NCT04405466 A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers https://ClinicalTrials.gov/show/NCT04405466
NCT04395885 Sexual Function During COVID 19 Pandemic https://ClinicalTrials.gov/show/NCT04395885
NCT04394884 Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND) https://ClinicalTrials.gov/show/NCT04394884
NCT04412460 Echocardiography in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04412460
NCT04411511 COVID-19, Obesity and Lifestyle in Children https://ClinicalTrials.gov/show/NCT04411511
NCT04403607 Cardiac Imaging in SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04403607
NCT04400812 Attitude and Perception Towards COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400812
NCT04400461 Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04400461
NCT04397172 Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 https://ClinicalTrials.gov/show/NCT04397172
NCT04473105 Optimising Resource Allocation Via Prediction of Outcomes for Covid-19 https://ClinicalTrials.gov/show/NCT04473105
NCT04427280 Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04427280
NCT04425382 Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar https://ClinicalTrials.gov/show/NCT04425382
NCT04402229 Psychological Impact of the Covid-19 Pandemic on Student Nurses https://ClinicalTrials.gov/show/NCT04402229
NCT04401371 Distance Learning for Dental Student During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04401371
NCT04401228 Predictive Models for Intensive Care Admission and Death of COVID-19 https://ClinicalTrials.gov/show/NCT04401228
NCT04401085 COVID-19: Herd Immunity Study in the Czech Republic https://ClinicalTrials.gov/show/NCT04401085
NCT04400006 Ozone Therapy in the Prevention of COVID-19 Infection https://ClinicalTrials.gov/show/NCT04400006
NCT04403035 Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 https://ClinicalTrials.gov/show/NCT04403035
NCT04410939 COVID-19 PCR Test Results in Asymptomatic Pregnants https://ClinicalTrials.gov/show/NCT04410939
NCT04404062 Validation of COVID-19 Tests https://ClinicalTrials.gov/show/NCT04404062
NCT04402853 SARS Cov-2 in Conjunctival Secretion https://ClinicalTrials.gov/show/NCT04402853
NCT04402814 IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With Nasopharyngeal PCR Testing. https://ClinicalTrials.gov/show/NCT04402814
NCT04401449 Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons https://ClinicalTrials.gov/show/NCT04401449
NCT04401098 Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak https://ClinicalTrials.gov/show/NCT04401098
NCT04401072 Attitude of Egyptian Population Toward COVID 19 in Ramadan https://ClinicalTrials.gov/show/NCT04401072
NCT04400877 Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400877
NCT04401436 COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) https://ClinicalTrials.gov/show/NCT04401436
NCT04403880 Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 https://ClinicalTrials.gov/show/NCT04403880
NCT04413071 Cardiac COVID-19 Health Care Workers https://ClinicalTrials.gov/show/NCT04413071
NCT04406545 Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. https://ClinicalTrials.gov/show/NCT04406545
NCT04406233 Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04406233
NCT04403438 Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic https://ClinicalTrials.gov/show/NCT04403438
NCT04403386 Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 https://ClinicalTrials.gov/show/NCT04403386
NCT04403061 Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome https://ClinicalTrials.gov/show/NCT04403061
NCT04402827 Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. https://ClinicalTrials.gov/show/NCT04402827
NCT04407299 COVID-19 Impact on Rheumatic Patients https://ClinicalTrials.gov/show/NCT04407299
NCT04404179 Setting up a COVID-19 Care Facility at a Prison in Pakistan https://ClinicalTrials.gov/show/NCT04404179
NCT04406558 Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents https://ClinicalTrials.gov/show/NCT04406558
NCT04403932 Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency https://ClinicalTrials.gov/show/NCT04403932
NCT04403828 Impact of COVID-19 on Personal Protection Among Dentist in Egypt https://ClinicalTrials.gov/show/NCT04403828
NCT04413435 Clinical Characteristics of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04413435
NCT04410107 Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 https://ClinicalTrials.gov/show/NCT04410107
NCT04408222 Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure https://ClinicalTrials.gov/show/NCT04408222
NCT04407143 Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04407143
NCT04406844 An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown https://ClinicalTrials.gov/show/NCT04406844
NCT04405973 Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO https://ClinicalTrials.gov/show/NCT04405973
NCT04405869 Thromboembolic Events in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04405869
NCT04405726 Prognostic Factors of COVID19 https://ClinicalTrials.gov/show/NCT04405726
NCT04404270 Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) https://ClinicalTrials.gov/show/NCT04404270
NCT04404244 Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04404244
NCT04435106 Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04435106
NCT04416100 Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) https://ClinicalTrials.gov/show/NCT04416100
NCT04411576 Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare https://ClinicalTrials.gov/show/NCT04411576
NCT04409899 The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department https://ClinicalTrials.gov/show/NCT04409899
NCT04406090 Endovascular Thrombectomy in COVID-19 Infected Patients https://ClinicalTrials.gov/show/NCT04406090
NCT04405232 Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK https://ClinicalTrials.gov/show/NCT04405232
NCT04406038 Study of the Spread of COVID-19 in Saint Petersburg, Russia https://ClinicalTrials.gov/show/NCT04406038
NCT04408170 Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) https://ClinicalTrials.gov/show/NCT04408170
NCT04445259 Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury https://ClinicalTrials.gov/show/NCT04445259
NCT04423640 Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423640
NCT04414410 Echocardiography in Critically-ill Patients With COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04414410
NCT04413058 Menstrual Cycle Characteristics of Healthcare Professionals https://ClinicalTrials.gov/show/NCT04413058
NCT04412473 COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits https://ClinicalTrials.gov/show/NCT04412473
NCT04408378 Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients https://ClinicalTrials.gov/show/NCT04408378
NCT04408326 Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04408326
NCT04407663 Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near https://ClinicalTrials.gov/show/NCT04407663
NCT04407585 Testing the Accuracy of a Digital Test to Diagnose Covid-19 https://ClinicalTrials.gov/show/NCT04407585
NCT04407572 Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women https://ClinicalTrials.gov/show/NCT04407572
NCT04407559 COVID-SErology in Rheumatoid Arthritis (COVID-19) https://ClinicalTrials.gov/show/NCT04407559
NCT04407546 Role of Children in Transmission of COVID-19 to Immunocompromised Patients https://ClinicalTrials.gov/show/NCT04407546
NCT04407533 Dietary Intake and Eating Habits During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407533
NCT04407494 Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) https://ClinicalTrials.gov/show/NCT04407494
NCT04407429 Vienna Versus SARS-CoV-2 Virus Study https://ClinicalTrials.gov/show/NCT04407429
NCT04407273 STATIN THERAPY AND COVID-19 INFECTION https://ClinicalTrials.gov/show/NCT04407273
NCT04407260 The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04407260
NCT04407117 Appendicitis During the National Lockdown During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04407117
NCT04406571 Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer https://ClinicalTrials.gov/show/NCT04406571
NCT04407468 Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04407468
NCT04425213 Obesity and Mortality of Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04425213
NCT04418609 Neuro-COVID-19: Neurological Complications of COVID-19 https://ClinicalTrials.gov/show/NCT04418609
NCT04409275 LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION https://ClinicalTrials.gov/show/NCT04409275
NCT04408001 Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff https://ClinicalTrials.gov/show/NCT04408001
NCT04407923 Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment https://ClinicalTrials.gov/show/NCT04407923
NCT04409249 Prognosis in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04409249
NCT04416373 COVID-19 and Pregnancy Outcomes https://ClinicalTrials.gov/show/NCT04416373
NCT04416256 COVID-19 Pandemic and Worldwide Organ Procurement https://ClinicalTrials.gov/show/NCT04416256
NCT04412031 Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient https://ClinicalTrials.gov/show/NCT04412031
NCT04411784 PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04411784
NCT04411459 Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome https://ClinicalTrials.gov/show/NCT04411459
NCT04410484 PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04410484
NCT04410432 Immune Response and Risk of Serious Infection to SARS-Cov2 https://ClinicalTrials.gov/show/NCT04410432
NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04412304
NCT04412278 Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers https://ClinicalTrials.gov/show/NCT04412278
NCT04412265 Frailty in Elderly Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04412265
NCT04411147 A Longitudinal Study of COVID-19 Sequelae and Immunity https://ClinicalTrials.gov/show/NCT04411147
NCT04448418 The Impact of COVID-19 Outbreak on Trans-population’s Health in Italy https://ClinicalTrials.gov/show/NCT04448418
NCT04418544 Vocal Feature Analysis Algorithm https://ClinicalTrials.gov/show/NCT04418544
NCT04416061 The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04416061
NCT04413045 Novel COVID-19, A National Analysis https://ClinicalTrials.gov/show/NCT04413045
NCT04412746 Covid-19 and Diabetes in West of Algeria https://ClinicalTrials.gov/show/NCT04412746
NCT04412655 Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry https://ClinicalTrials.gov/show/NCT04412655
NCT04418193 Patient Preference Trial for COVID-19 (PPT-COVID) https://ClinicalTrials.gov/show/NCT04418193
NCT04414657 USZ BioResource COVID https://ClinicalTrials.gov/show/NCT04414657
NCT04443075 Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress https://ClinicalTrials.gov/show/NCT04443075
NCT04422535 Effects on the Qt Interval of COVID-19 Coronavirus Infection https://ClinicalTrials.gov/show/NCT04422535
NCT04422418 Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi https://ClinicalTrials.gov/show/NCT04422418
NCT04418284 Online Learning of Veterinary Anatomy During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04418284
NCT04427345 Predictive Factors COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427345
NCT04424992 The Natural History of Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424992
NCT04422873 The Impact of COVID-19 on Dialysis Users https://ClinicalTrials.gov/show/NCT04422873
NCT04422769 Needs of Persons With Spinal Cord Injury (SCI) https://ClinicalTrials.gov/show/NCT04422769
NCT04420416 Mental Health and Academic Performance in COVID-19 https://ClinicalTrials.gov/show/NCT04420416
NCT04419545 Covid Radiographic Images Data-set for A.I https://ClinicalTrials.gov/show/NCT04419545
NCT04418245 CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis https://ClinicalTrials.gov/show/NCT04418245
NCT04420637 Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases https://ClinicalTrials.gov/show/NCT04420637
NCT04419571 Peri-Operative NLR in Emergency General Surgery During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04419571
NCT04424355 Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. https://ClinicalTrials.gov/show/NCT04424355
NCT04420312 Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04420312
NCT04420286 Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France https://ClinicalTrials.gov/show/NCT04420286
NCT04419870 Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic https://ClinicalTrials.gov/show/NCT04419870
NCT04425889 COVID-19 Antibodies Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04425889
NCT04427969 Early Prone Position on Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04427969
NCT04424771 Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia https://ClinicalTrials.gov/show/NCT04424771
NCT04423692 Knowledge About Covid-19 Infection https://ClinicalTrials.gov/show/NCT04423692
NCT04422522 Fibromyalgia During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04422522
NCT04424836 HFNC Treatment in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04424836
NCT04426266 Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population https://ClinicalTrials.gov/show/NCT04426266
NCT04425863 IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19 https://ClinicalTrials.gov/show/NCT04425863
NCT04425850 USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 https://ClinicalTrials.gov/show/NCT04425850
NCT04424849 Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04424849
NCT04423978 Implications of Covid-19 on the Lifestyle Changes https://ClinicalTrials.gov/show/NCT04423978
NCT04422574 COVID 19 Serology in Pulmonologists https://ClinicalTrials.gov/show/NCT04422574
NCT04422340 Senior-COVID-Rea Multicentric Survey https://ClinicalTrials.gov/show/NCT04422340
NCT04424004 MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study https://ClinicalTrials.gov/show/NCT04424004
NCT04423770 COVID-19 Related Health and Infection Control Practices Among Dentists https://ClinicalTrials.gov/show/NCT04423770
NCT04424017 Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers https://ClinicalTrials.gov/show/NCT04424017
NCT04427735 Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI https://ClinicalTrials.gov/show/NCT04427735
NCT04426253 Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 https://ClinicalTrials.gov/show/NCT04426253
NCT04425044 AiM Covid Self Monitoring https://ClinicalTrials.gov/show/NCT04425044
NCT04431414 A Study of Immune Responses to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04431414
NCT04424446 Saliva/Nares as Source of Detection for SARS-CoV-2 at NIH https://ClinicalTrials.gov/show/NCT04424446
NCT04430023 Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia https://ClinicalTrials.gov/show/NCT04430023
NCT04429620 Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method https://ClinicalTrials.gov/show/NCT04429620
NCT04427358 RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population https://ClinicalTrials.gov/show/NCT04427358
NCT04427332 Smell and Taste Disorders in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427332
NCT04427267 Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients https://ClinicalTrials.gov/show/NCT04427267
NCT04431284 Impact of COVID-19 Lockdown on Obesity and Eating Behaviors https://ClinicalTrials.gov/show/NCT04431284
NCT04427176 Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19). https://ClinicalTrials.gov/show/NCT04427176
NCT04438239 Rehabilitation Needs After COVID-19 Hospital Treatment https://ClinicalTrials.gov/show/NCT04438239
NCT04447222 Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors https://ClinicalTrials.gov/show/NCT04447222
NCT04430322 Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study https://ClinicalTrials.gov/show/NCT04430322
NCT04430062 Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital https://ClinicalTrials.gov/show/NCT04430062
NCT04441502 Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic https://ClinicalTrials.gov/show/NCT04441502
NCT04436484 Immune Biomarkers of Outcome From COVID-19 https://ClinicalTrials.gov/show/NCT04436484
NCT04435327 Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04435327
NCT04435119 Covid-19 and Vitamin D in Nursing-home https://ClinicalTrials.gov/show/NCT04435119
NCT04434157 Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04434157
NCT04433754 The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection https://ClinicalTrials.gov/show/NCT04433754
NCT04433000 Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia https://ClinicalTrials.gov/show/NCT04433000
NCT04459975 Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units https://ClinicalTrials.gov/show/NCT04459975
NCT04432870 Patients’ Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study https://ClinicalTrials.gov/show/NCT04432870
NCT04434118 Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients https://ClinicalTrials.gov/show/NCT04434118
NCT04433039 COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising https://ClinicalTrials.gov/show/NCT04433039
NCT04432948 Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management. https://ClinicalTrials.gov/show/NCT04432948
NCT04437121 Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece https://ClinicalTrials.gov/show/NCT04437121
NCT04435080 Physical Rehabilitation in ICU in ARDS Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04435080
NCT04435028 Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy https://ClinicalTrials.gov/show/NCT04435028
NCT04434261 Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 https://ClinicalTrials.gov/show/NCT04434261
NCT04451694 Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19 https://ClinicalTrials.gov/show/NCT04451694
NCT04456010 COVID-19 in ART: Perception and Experience https://ClinicalTrials.gov/show/NCT04456010
NCT04438967 Brain Health in the Time of COVID-19 https://ClinicalTrials.gov/show/NCT04438967
NCT04437342 Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia https://ClinicalTrials.gov/show/NCT04437342
NCT04443712 Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19) https://ClinicalTrials.gov/show/NCT04443712
NCT04441489 Assessment of Lung Inflammation With FDG PET/CT in COVID-19 https://ClinicalTrials.gov/show/NCT04441489
NCT04438629 Evaluation of Immune Response in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04438629
NCT04435223 Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen https://ClinicalTrials.gov/show/NCT04435223
NCT04447209 Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study https://ClinicalTrials.gov/show/NCT04447209
NCT04447131 Effect of COVID-19 on Platelet Aggregation https://ClinicalTrials.gov/show/NCT04447131
NCT04441476 Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis https://ClinicalTrials.gov/show/NCT04441476
NCT04439084 COVID-19 in Patients With Chronic Liver Diseases https://ClinicalTrials.gov/show/NCT04439084
NCT04438954 Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels https://ClinicalTrials.gov/show/NCT04438954
NCT04438941 Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic https://ClinicalTrials.gov/show/NCT04438941
NCT04437940 Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test https://ClinicalTrials.gov/show/NCT04437940
NCT04448782 Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04448782
NCT04448717 Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children https://ClinicalTrials.gov/show/NCT04448717
NCT04442789 Sequelae of Sars-CoV-2 Infections https://ClinicalTrials.gov/show/NCT04442789
NCT04441814 FOUND - Ancillary Study to Smile Protocol NCT03654105 https://ClinicalTrials.gov/show/NCT04441814
NCT04440098 Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology https://ClinicalTrials.gov/show/NCT04440098
NCT04438993 The COVID-19 Disease and CARdiac Events Study https://ClinicalTrials.gov/show/NCT04438993
NCT04459351 PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs https://ClinicalTrials.gov/show/NCT04459351
NCT04445506 Short Term Corticosteroids in SARS-CoV2 Patients https://ClinicalTrials.gov/show/NCT04445506
NCT04444661 Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise https://ClinicalTrials.gov/show/NCT04444661
NCT04448405 Covid-19 Lockdown and Deviant Sexual Fantasies https://ClinicalTrials.gov/show/NCT04448405
NCT04462120 IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study https://ClinicalTrials.gov/show/NCT04462120
NCT04446169 COVID-19 (SARS-CoV-2) in Urine and Semen https://ClinicalTrials.gov/show/NCT04446169
NCT04444557 Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study https://ClinicalTrials.gov/show/NCT04444557
NCT04452682 The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice https://ClinicalTrials.gov/show/NCT04452682
NCT04446338 Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre https://ClinicalTrials.gov/show/NCT04446338
NCT04445961 Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure https://ClinicalTrials.gov/show/NCT04445961
NCT04445233 COVID-19 Household Transmission Study https://ClinicalTrials.gov/show/NCT04445233
NCT04444531 Clinical Improvement and COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04444531
NCT04445441 An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso https://ClinicalTrials.gov/show/NCT04445441
NCT04459533 Sparing in Neuromuscular Blockade in COVID 19 ICU https://ClinicalTrials.gov/show/NCT04459533
NCT04444401 Registry on NEN Patients and COVID-19 https://ClinicalTrials.gov/show/NCT04444401
NCT04450017 Clinical Features of Severe Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04450017
NCT04449978 TARGet Kids! COVID-19 Study of Children and Families https://ClinicalTrials.gov/show/NCT04449978
NCT04448054 Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas https://ClinicalTrials.gov/show/NCT04448054
NCT04445870 Oncology Care Pathway’s Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study https://ClinicalTrials.gov/show/NCT04445870
NCT04452422 Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology https://ClinicalTrials.gov/show/NCT04452422
NCT04447144 Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome https://ClinicalTrials.gov/show/NCT04447144
NCT04446286 Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 https://ClinicalTrials.gov/show/NCT04446286
NCT04449731 Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) https://ClinicalTrials.gov/show/NCT04449731
NCT04448145 Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence https://ClinicalTrials.gov/show/NCT04448145
NCT04447638 Percutaneous Tracheostomy With COVID-19 https://ClinicalTrials.gov/show/NCT04447638
NCT04449094 Emergence of the COVID 19 Epidemic in the City of Nice https://ClinicalTrials.gov/show/NCT04449094
NCT04449081 Knowledge, Attitude and Practice of Dental Students About COVID-19 https://ClinicalTrials.gov/show/NCT04449081
NCT04451577 Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection https://ClinicalTrials.gov/show/NCT04451577
NCT04448704 Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04448704
NCT04453527 The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19 https://ClinicalTrials.gov/show/NCT04453527
NCT04453501 Anti Infective Agents Impact in COVID-19 Pneumonia https://ClinicalTrials.gov/show/NCT04453501
NCT04452630 Cardiovascular Consequences After COVID-19 https://ClinicalTrials.gov/show/NCT04452630
NCT04452617 Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04452617
NCT04451993 Physical Activity Level in Patients With OSAS During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04451993
NCT04458337 SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19) https://ClinicalTrials.gov/show/NCT04458337
NCT04459819 Respiratory Physiotherapy in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04459819
NCT04452708 HFNC and NIV for COVID-19 Complicated by Respiratory Failure https://ClinicalTrials.gov/show/NCT04452708
NCT04452695 Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 https://ClinicalTrials.gov/show/NCT04452695
NCT04453982 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b https://ClinicalTrials.gov/show/NCT04453982
NCT04453969 Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a https://ClinicalTrials.gov/show/NCT04453969
NCT04453566 Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes. https://ClinicalTrials.gov/show/NCT04453566
NCT04456075 Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 https://ClinicalTrials.gov/show/NCT04456075
NCT04463628 Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic https://ClinicalTrials.gov/show/NCT04463628
NCT04474249 Follow-up of Critical COVID-19 Patients https://ClinicalTrials.gov/show/NCT04474249
NCT04469153 Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19 https://ClinicalTrials.gov/show/NCT04469153
NCT04454333 COVID-19 in Pain Perspective https://ClinicalTrials.gov/show/NCT04454333
NCT04453280 Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) https://ClinicalTrials.gov/show/NCT04453280
NCT04456556 Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19) https://ClinicalTrials.gov/show/NCT04456556
NCT04456933 Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study https://ClinicalTrials.gov/show/NCT04456933
NCT04475471 WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey https://ClinicalTrials.gov/show/NCT04475471
NCT04457570 Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer https://ClinicalTrials.gov/show/NCT04457570
NCT04459403 Psychiatric Disturbances and COVID-19 Infection https://ClinicalTrials.gov/show/NCT04459403
NCT04460274 Forecast Number of Covid-19 Cases Worldwide https://ClinicalTrials.gov/show/NCT04460274
NCT04459312 National Covid-19 Surveillance Physicians https://ClinicalTrials.gov/show/NCT04459312
NCT04460469 Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic https://ClinicalTrials.gov/show/NCT04460469
NCT04462393 Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 https://ClinicalTrials.gov/show/NCT04462393
NCT04460599 Neurological Features During COVID19 https://ClinicalTrials.gov/show/NCT04460599
NCT04467931 ACEI or ARB and COVID-19 Severity and Mortality in US Veterans https://ClinicalTrials.gov/show/NCT04467931
NCT04475484 Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children https://ClinicalTrials.gov/show/NCT04475484
NCT04463706 COVID19 Severity Prediction and Health Services Research Evaluation https://ClinicalTrials.gov/show/NCT04463706
NCT04465981 Investigation of Antibody and Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or COVID-19 Proteins https://ClinicalTrials.gov/show/NCT04465981
NCT04474236 Lung Ultrasound for COVID-19 Initial Triage and Monitoring https://ClinicalTrials.gov/show/NCT04474236
NCT04471649 Hydroxy Chloroquine and Covid in RA Patients https://ClinicalTrials.gov/show/NCT04471649
NCT04465058 Characteristics of Critically Ill COVID 19 Patients https://ClinicalTrials.gov/show/NCT04465058
NCT04463758 Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns https://ClinicalTrials.gov/show/NCT04463758
NCT04466462 Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel https://ClinicalTrials.gov/show/NCT04466462
NCT04468386 Specimen Collection Study Protocol https://ClinicalTrials.gov/show/NCT04468386
NCT04466644 COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) https://ClinicalTrials.gov/show/NCT04466644
NCT04468217 Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR https://ClinicalTrials.gov/show/NCT04468217
NCT04466982 Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection https://ClinicalTrials.gov/show/NCT04466982
NCT04468802 Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries? https://ClinicalTrials.gov/show/NCT04468802
NCT04468035 Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation https://ClinicalTrials.gov/show/NCT04468035
NCT04474444 Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP) https://ClinicalTrials.gov/show/NCT04474444
NCT04471051 An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients https://ClinicalTrials.gov/show/NCT04471051
NCT04469660 Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India https://ClinicalTrials.gov/show/NCT04469660
NCT04469647 COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH https://ClinicalTrials.gov/show/NCT04469647
NCT04474301 Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04474301
NCT04473547 COVID 19 Preventive Measures Among Mansoura Nursing Students https://ClinicalTrials.gov/show/NCT04473547
NCT04473300 Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography https://ClinicalTrials.gov/show/NCT04473300
NCT04471701 Italian Web-based Cross-sectional Survey on COVID-19 https://ClinicalTrials.gov/show/NCT04471701
NCT04474457 Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age: A Multi-centre Observational Study https://ClinicalTrials.gov/show/NCT04474457
NCT04474067 A Multi-Center Study Evaluating Clinical Course in Patients With COVID19 and Its Relationship to Cytokine Storm https://ClinicalTrials.gov/show/NCT04474067
NCT04473157 COVID-19 in Patients With Anosmia in Egypt https://ClinicalTrials.gov/show/NCT04473157
NCT04473131 Immune Profiling of COVID19-patients Admitted to ICU https://ClinicalTrials.gov/show/NCT04473131
NCT04473118 Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients https://ClinicalTrials.gov/show/NCT04473118

Registrires

nct_id brief_title link
NCT04314271 The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia https://ClinicalTrials.gov/show/NCT04314271
NCT04318314 COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 https://ClinicalTrials.gov/show/NCT04318314
NCT04315870 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. https://ClinicalTrials.gov/show/NCT04315870
NCT04323592 Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome https://ClinicalTrials.gov/show/NCT04323592
NCT04319016 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy https://ClinicalTrials.gov/show/NCT04319016
NCT04320472 Acute Encephalopathy in Critically Ill Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04320472
NCT04321811 Behavior, Environment And Treatments for Covid-19 https://ClinicalTrials.gov/show/NCT04321811
NCT04323839 COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) https://ClinicalTrials.gov/show/NCT04323839
NCT04325412 Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY https://ClinicalTrials.gov/show/NCT04325412
NCT04327570 In-depth Immunological Investigation of COVID-19. https://ClinicalTrials.gov/show/NCT04327570
NCT04327479 Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection https://ClinicalTrials.gov/show/NCT04327479
NCT04327674 The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 https://ClinicalTrials.gov/show/NCT04327674
NCT04329559 COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study https://ClinicalTrials.gov/show/NCT04329559
NCT04331574 Renin-Angiotensin System Inhibitors and COVID-19 https://ClinicalTrials.gov/show/NCT04331574
NCT04331171 Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage https://ClinicalTrials.gov/show/NCT04331171
NCT04336956 Covid-19 Pediatric Observatory https://ClinicalTrials.gov/show/NCT04336956
NCT04333953 COVID-19 in Patients With HIV https://ClinicalTrials.gov/show/NCT04333953
NCT04334291 International COVID19 Clinical Evaluation Registry, https://ClinicalTrials.gov/show/NCT04334291
NCT04333875 Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis https://ClinicalTrials.gov/show/NCT04333875
NCT04341766 Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 https://ClinicalTrials.gov/show/NCT04341766
NCT04336345 Outcomes of Patients With COVID-19 in the Intensive Care Unit https://ClinicalTrials.gov/show/NCT04336345
NCT04347278 Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry https://ClinicalTrials.gov/show/NCT04347278
NCT04335773 COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology https://ClinicalTrials.gov/show/NCT04335773
NCT04345536 Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital https://ClinicalTrials.gov/show/NCT04345536
NCT04337346 Evaluation of Covid 19 Anxiety in Endometriosis Patients https://ClinicalTrials.gov/show/NCT04337346
NCT04354519 The United Kingdom Multiple Sclerosis Register Covid-19 Substudy https://ClinicalTrials.gov/show/NCT04354519
NCT04353583 Renal Outcome in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04353583
NCT04340466 French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study https://ClinicalTrials.gov/show/NCT04340466
NCT04344249 Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04344249
NCT04344002 LunG canceR pAtients coVId19 Disease (GRAVID) https://ClinicalTrials.gov/show/NCT04344002
NCT04349982 ICU Trial in Critical Ill COVID‐19 Patients https://ClinicalTrials.gov/show/NCT04349982
NCT04348227 How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? https://ClinicalTrials.gov/show/NCT04348227
NCT04344912 Impact of COVID19 Outbreak in Cardiac Acute Care https://ClinicalTrials.gov/show/NCT04344912
NCT04348942 A COVID-19 Symptom, Exposure and Immune Response Registry https://ClinicalTrials.gov/show/NCT04348942
NCT04347993 A Prospective “Universal” Observational Database for COVID-19 https://ClinicalTrials.gov/show/NCT04347993
NCT04347798 IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT https://ClinicalTrials.gov/show/NCT04347798
NCT04378452 Assessment of the Psycho-social Impact of COVID-19 Outbreak https://ClinicalTrials.gov/show/NCT04378452
NCT04357275 The RIsk Stratification in COVID-19 Patients in the ICU Registry https://ClinicalTrials.gov/show/NCT04357275
NCT04354818 Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) https://ClinicalTrials.gov/show/NCT04354818
NCT04354701 COVID-19 and Cancer Consortium Registry https://ClinicalTrials.gov/show/NCT04354701
NCT04352764 ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings https://ClinicalTrials.gov/show/NCT04352764
NCT04351529 Austrian COVID-19 Registry https://ClinicalTrials.gov/show/NCT04351529
NCT04356586 Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms https://ClinicalTrials.gov/show/NCT04356586
NCT04366206 Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est https://ClinicalTrials.gov/show/NCT04366206
NCT04357639 Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) https://ClinicalTrials.gov/show/NCT04357639
NCT04380766 Covid-19 Pandemic and Pancreatic Surgery in Italy https://ClinicalTrials.gov/show/NCT04380766
NCT04359927 Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry https://ClinicalTrials.gov/show/NCT04359927
NCT04359602 COVID-19 Recovered Volunteer Research Participant Pool Registry https://ClinicalTrials.gov/show/NCT04359602
NCT04374110 Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04374110
NCT04361591 COVID-19 in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT04361591
NCT04361500 Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter https://ClinicalTrials.gov/show/NCT04361500
NCT04366986 International Registry of Coronavirus (COVID-19) Exposure in Pregnancy https://ClinicalTrials.gov/show/NCT04366986
NCT04364984 ARB, ACEi, DRi in COVID-19 https://ClinicalTrials.gov/show/NCT04364984
NCT04363632 Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection https://ClinicalTrials.gov/show/NCT04363632
NCT04433871 COVID-19 in Pediatric Oncology and Hematology Centers in France https://ClinicalTrials.gov/show/NCT04433871
NCT04365322 Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) https://ClinicalTrials.gov/show/NCT04365322
NCT04393142 Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 https://ClinicalTrials.gov/show/NCT04393142
NCT04368975 ARDS Caused by COVID-19 https://ClinicalTrials.gov/show/NCT04368975
NCT04370821 COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers https://ClinicalTrials.gov/show/NCT04370821
NCT04368234 Duke COVID-19 Shared Data and Specimen Repository https://ClinicalTrials.gov/show/NCT04368234
NCT04368143 COVID-19 Immune Repertoire Sequencing https://ClinicalTrials.gov/show/NCT04368143
NCT04367714 Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 https://ClinicalTrials.gov/show/NCT04367714
NCT04380727 Almitrine and COVID-19 Related Hypoxemia https://ClinicalTrials.gov/show/NCT04380727
NCT04370067 HUNgarian COronaVirus Disease-19 Epidemiological Research https://ClinicalTrials.gov/show/NCT04370067
NCT04368065 Registry to Study Factors That May Impact COVID-19 Occurrence and Severity https://ClinicalTrials.gov/show/NCT04368065
NCT04367857 ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers https://ClinicalTrials.gov/show/NCT04367857
NCT04367350 Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement https://ClinicalTrials.gov/show/NCT04367350
NCT04369300 Anxiety And Depression During COVID-19 IN INDIA https://ClinicalTrials.gov/show/NCT04369300
NCT04372199 SEVERITY SCORE FOR COVID-19 PNEUMONIA https://ClinicalTrials.gov/show/NCT04372199
NCT04371328 Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection https://ClinicalTrials.gov/show/NCT04371328
NCT04374045 Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study https://ClinicalTrials.gov/show/NCT04374045
NCT04373759 Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs https://ClinicalTrials.gov/show/NCT04373759
NCT04371744 QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 https://ClinicalTrials.gov/show/NCT04371744
NCT04379440 Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) https://ClinicalTrials.gov/show/NCT04379440
NCT04383457 Covid-19 Triage Using Camera-based AI https://ClinicalTrials.gov/show/NCT04383457
NCT04379544 Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 https://ClinicalTrials.gov/show/NCT04379544
NCT04376398 Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals https://ClinicalTrials.gov/show/NCT04376398
NCT04390555 The Global PCHF-COVICAV Registry https://ClinicalTrials.gov/show/NCT04390555
NCT04388605 Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic https://ClinicalTrials.gov/show/NCT04388605
NCT04388436 Post Covid-19 Cardiopulmonary and Immunological Changes https://ClinicalTrials.gov/show/NCT04388436
NCT04386265 Compassionate Use of Hyperbaric Oxygen Therapy https://ClinicalTrials.gov/show/NCT04386265
NCT04389996 COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey https://ClinicalTrials.gov/show/NCT04389996
NCT04388631 Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. https://ClinicalTrials.gov/show/NCT04388631
NCT04397575 The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients https://ClinicalTrials.gov/show/NCT04397575
NCT04387929 Detection of Anti-COVID-19 Antibody Levels in an Hospital Population https://ClinicalTrials.gov/show/NCT04387929
NCT04389554 D-dimer Levels in Pregnant With COVID-19 https://ClinicalTrials.gov/show/NCT04389554
NCT04391686 Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context https://ClinicalTrials.gov/show/NCT04391686
NCT04394000 Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 https://ClinicalTrials.gov/show/NCT04394000
NCT04393324 The Critical Care Response to the COVID-19 Pandemic in Madrid https://ClinicalTrials.gov/show/NCT04393324
NCT04394390 Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? https://ClinicalTrials.gov/show/NCT04394390
NCT04408339 COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking https://ClinicalTrials.gov/show/NCT04408339
NCT04395794 SARS-CoV-2 Disguise Study https://ClinicalTrials.gov/show/NCT04395794
NCT04401033 Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) https://ClinicalTrials.gov/show/NCT04401033
NCT04453748 The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications https://ClinicalTrials.gov/show/NCT04453748
NCT04401540 Characteristics of Neonatal Covid-19 in Turkey https://ClinicalTrials.gov/show/NCT04401540
NCT04403672 Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04403672
NCT04411563 Epigenetic Tools as Prognostic Predictors in Covid19 https://ClinicalTrials.gov/show/NCT04411563
NCT04412382 Covid-19: Possible Role of Neutrophil Extracellular Traps https://ClinicalTrials.gov/show/NCT04412382
NCT04410471 Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients https://ClinicalTrials.gov/show/NCT04410471
NCT04412317 Use of PCR-Sars-CoV-2 in Children https://ClinicalTrials.gov/show/NCT04412317
NCT04416009 Extracellular Water in Covid 19 Pneumonia https://ClinicalTrials.gov/show/NCT04416009
NCT04412551 Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 https://ClinicalTrials.gov/show/NCT04412551
NCT04418557 COVID-19 and Obstetric Transmission https://ClinicalTrials.gov/show/NCT04418557
NCT04422444 Post Intensive Care Syndrome in COVID19 Patients https://ClinicalTrials.gov/show/NCT04422444
NCT04422587 Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea https://ClinicalTrials.gov/show/NCT04422587
NCT04425759 Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) https://ClinicalTrials.gov/show/NCT04425759
NCT04423003 Endoscopic Interventions in Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04423003
NCT04422470 Registry of Patients With Hematologic Disease and COVID-19 in Russia https://ClinicalTrials.gov/show/NCT04422470
NCT04434144 A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh https://ClinicalTrials.gov/show/NCT04434144
NCT04429477 Cerebral Compliance Impairment in COVID-19 https://ClinicalTrials.gov/show/NCT04429477
NCT04426084 Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study https://ClinicalTrials.gov/show/NCT04426084
NCT04430374 Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf https://ClinicalTrials.gov/show/NCT04430374
NCT04433364 COPE - COVID-19 in Pregnancy and Early Childhood https://ClinicalTrials.gov/show/NCT04433364
NCT04435041 Remote-by-Default Care in the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04435041
NCT04444310 Antibody Responses in Contacts of COVID-19 Patients https://ClinicalTrials.gov/show/NCT04444310
NCT04443140 Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? https://ClinicalTrials.gov/show/NCT04443140
NCT04449042 The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry https://ClinicalTrials.gov/show/NCT04449042
NCT04445402 Pediatrics HOT COVID-19 Database in NY Tristate https://ClinicalTrials.gov/show/NCT04445402
NCT04466306 Pediatric Acute Kidney Injury in COVID-19 https://ClinicalTrials.gov/show/NCT04466306
NCT04450277 Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04450277
NCT04453579 Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health https://ClinicalTrials.gov/show/NCT04453579
NCT04455347 Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked https://ClinicalTrials.gov/show/NCT04455347
NCT04457505 One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 https://ClinicalTrials.gov/show/NCT04457505
NCT04459689 COVID-19 in PID Survey https://ClinicalTrials.gov/show/NCT04459689
NCT04459364 The Prevalence of Pulmonary Hypertension in Patients With COVID-19. https://ClinicalTrials.gov/show/NCT04459364
NCT04465474 Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission https://ClinicalTrials.gov/show/NCT04465474
NCT04460196 Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments https://ClinicalTrials.gov/show/NCT04460196
NCT04463862 Air Pollution and COVID-19 Mortality in Geriatric Patients: a Multicenter Study https://ClinicalTrials.gov/show/NCT04463862
NCT04472078 Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina https://ClinicalTrials.gov/show/NCT04472078